{
  "meta": {
    "title": "00239_Mid_Day_Module_Biochemistry-2",
    "url": "https://brainandscalpel.vercel.app/00239-mid-day-module-biochemistry-2-784c9f4d.html",
    "scrapedAt": "2025-11-29T18:14:33.305Z"
  },
  "questions": [
    {
      "id": 9052,
      "choices": [
        {
          "id": 36175,
          "text": "<p><span style=\"font-size:12.0pt;\">Familial Chylomicronemia</span></p>"
        },
        {
          "id": 36176,
          "text": "<p><span style=\"font-size:12.0pt;\">Type III Hyperlipoproteinemia</span></p>"
        },
        {
          "id": 36177,
          "text": "<p><span style=\"font-size:12.0pt;\">Abetalipoproteinemia</span></p>"
        },
        {
          "id": 36178,
          "text": "<p><span style=\"font-size:12.0pt;\">Type IIa Hyperlipoproteinemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old student has been experiencing yellowish discoloration of the palms for the past seven months, with no changes in sclera or mucous membranes and no history of chemical exposure. His lipid profile shows the below results: Laboratory investigations:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/8_IvdwEdI.jpg\" alt=\"\" width=\"398\" height=\"134\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Total cholesterol: 240 mg/dl (N = &lt; 200 mg/dl)&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">LDL cholesterol: 145 mg/dl&nbsp;(N = &lt; 100 mg/dl)&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">TG: 250 mg/dl&nbsp;(N = 60-150 mg/dl)&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">HDL cholesterol: 45 mg/dl &nbsp;(N = 40-75 mg/dl)&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Lipoprotein electrophoresis shows a broad beta band.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given these findings, what is the most likely diagnosis?</span></p>",
      "unique_key": "Q1291107",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924668,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Type III Hyperlipoproteinemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Type III Hyperlipoproteinemia</strong>, also known as <strong>dysbetalipoproteinemia</strong> or <strong>broad beta disease</strong>, is caused by a defect in <strong>apolipoprotein E (apoE)</strong>, which impairs the clearance of <strong>chylomicron remnants and IDL</strong> from the plasma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key features include:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Elevated total cholesterol and triglycerides</strong> (typically both increased)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Broad beta band on electrophoresis</strong>, due to accumulation of remnant lipoproteins</span></li><li><span style=\"font-size:12.0pt;\"><strong>Palmar xanthomas</strong> — yellowish discoloration or deposits in the creases of the palms</span></li><li><span style=\"font-size:12.0pt;\"><strong>Increased risk of premature atherosclerosis</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient’s <strong>lipid pattern</strong>, <strong>broad beta band</strong>, and <strong>palmar discoloration</strong> (xanthomas) are classic for <strong>Type III Hyperlipoproteinemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. Familial Chylomicronemia (Type I)</strong> – Presents with <strong>very high triglycerides</strong>, <strong>creamy plasma</strong>, and <strong>eruptive xanthomas</strong>, usually without a broad beta band.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Abetalipoproteinemia</strong> – Features <strong>very low or absent apoB-containing lipoproteins</strong>, leading to <strong>low cholesterol and triglycerides</strong>, <strong>fat malabsorption</strong>, and <strong>acanthocytosis</strong>. Not seen here.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Type IIa Hyperlipoproteinemia (Familial Hypercholesterolemia)</strong> – Characterized by <strong>isolated elevated LDL</strong>, <strong>normal triglycerides</strong>, and <strong>tendon xanthomas</strong>. Not compatible with this lipid profile.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Recognize <strong>Type III Hyperlipoproteinemia</strong> by its unique clinical features:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Combined elevation of cholesterol and triglycerides</span></li><li><span style=\"font-size:12.0pt;\"><strong>Broad beta band</strong> on electrophoresis</span></li><li><span style=\"font-size:12.0pt;\"><strong>Palmar xanthomas</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Vasudevan 9 /ed: p245, 246.</span></p>",
      "correct_choice_id": 36176,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7674,
      "choices": [
        {
          "id": 30664,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finger-like projection</span></span></span></p>"
        },
        {
          "id": 30665,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cysteine residues</span></span></span></p>"
        },
        {
          "id": 30666,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leucine residues</span></span></span></p>"
        },
        {
          "id": 30667,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SH group of proteins</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong>&nbsp;</strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Following is an image of a Zinc finger domain of a steroid receptor. Which of the following molecule is stabilising Zinc in this structure?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture4.jpg\" style=\"height:415px; width:300px\" /></p>",
      "unique_key": "Q6341929",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924666,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">cysteine residues</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the structure of a <strong>zinc finger domain</strong>, <strong>zinc ions </strong>are typically <strong>coordinated by cysteine and/or histidine residues</strong>. These<strong> residues</strong> provide the <strong>necessary</strong> coordination <strong>complex to stabilize </strong>the <strong>zinc ion </strong>within the <strong>motif,</strong> contributing to the <strong>structural integrity</strong> required for the<strong> domain to perform its function in DNA binding.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Finger-like projection</strong> - This option might be a <strong>conceptual misunderstanding</strong>. The term &quot;<strong>zinc finger&quot;</strong> refers to the <strong>shape of</strong> the <strong>protein domain</strong>, <strong>not</strong> a <strong>physical structure</strong> that <strong>stabilizes zinc</strong>. Thus, &quot;<strong>finger-like projection&quot; </strong>does<strong> not </strong>refer to a <strong>stabilizing</strong> <strong>molecule.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Leucine residues</strong> - Leucine residues are <strong>not </strong>typically involved in the<strong> coordination of zinc ions within zinc finger motifs</strong>. <strong>Zinc fingers </strong>usually <strong>require cysteine and/or histidine residues </strong>for <strong>metal ion coordination.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>SH group of proteins</strong> - While the<strong> sulfhydryl (SH) group</strong> found in <strong>cysteine residues</strong> does <strong>interact with zinc,</strong> this option is <strong>less precise </strong>than specifying <strong>cysteine residues directly.</strong> The <strong>SH group</strong> contributes to the<strong> bond with zinc </strong>but does <strong>not </strong>describe the <strong>full</strong> <strong>residue</strong> or<strong> its context </strong>within the <strong>protein structure.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other <strong>DNA binding domains</strong> with<strong> their functions</strong> are shown in the following table.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture5.jpg\" style=\"height:482px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 444</span></strong></span></span></p>",
      "correct_choice_id": 30665,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9063,
      "choices": [
        {
          "id": 36219,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></span></span></p>"
        },
        {
          "id": 36220,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></span></span></p>"
        },
        {
          "id": 36221,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL</span></span></span></p>"
        },
        {
          "id": 36222,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A physician is consulting a patient about his elevated triglyceride levels. The patient is non-diabetic and has no history of alcohol overuse, factors known to influence triglyceride levels. The physician explains that a certain lipoprotein is primarily responsible for transporting triglycerides synthesized by the liver. Which lipoprotein does the liver use to transport these endogenous triglycerides?</span></span></span></p>",
      "unique_key": "Q9333320",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924675,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) VLDL</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Very Low-Density Lipoproteins (VLDL) </strong>are produced by the <strong>liver </strong>and are responsible for <strong>transporting endogenous triacylglycerols,</strong> which are synthesized by the liver, <strong>to adipose tissue and muscle</strong>. <strong>VLDL</strong> serves as the <strong>body&#39;s internal transport </strong>mechanism for lipids it has<strong> produced or extracted from the diet and processed.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Chylomicrons</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These <strong>transport dietary, or exogenous, lipids </strong>from the <strong>intestines to other tissues </strong>in the body after a<strong> meal.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: LDL</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Primarily carries<strong> cholesterol to the body&#39;s cells</strong> rather than triacylglycerol.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: HDL</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Involved in<strong> reverse cholesterol transport,</strong> carrying <strong>cholesterol from the tissues back to the liver</strong>, and is <strong>not </strong>a primary carrier of <strong>triacylglycerol.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-110237.png\" style=\"height:490px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p 226.</span></strong></span></span></p>",
      "correct_choice_id": 36220,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9069,
      "choices": [
        {
          "id": 36243,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CPS&ndash;I</span></span></span></p>"
        },
        {
          "id": 36244,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone sensitive lipase</span></span></span></p>"
        },
        {
          "id": 36245,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogen Phosphorylase</span></span></span></p>"
        },
        {
          "id": 36246,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl CoA carboxylase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A research team studying metabolic responses to nutrient deprivation measures enzymatic activities in subjects after a 24-hour fast. They aim to determine which enzyme associated with lipid metabolism shows decreased activity in this energy-conserving state. Which enzyme is the research team least likely to find elevated in the fasting state?</span></span></span></p>",
      "unique_key": "Q4108234",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924677,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl CoA carboxylase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phosphorylation inactivates acetyl CoA carboxylase. </strong>Thus, <strong>AMP activated kinase </strong>(AMPK) <strong>phosphorylates acetyl CoA carboxylase </strong>and <strong>inactivates </strong>it</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>ATP inhibits AMPK</strong>, hence <strong>fatty acid synthesis </strong>is <strong>increased </strong>in a <strong>well-fed state</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fatty acid synthesis decreases </strong>in <strong>fasting state</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>This </strong>enzyme is <strong>inhibited </strong>by <strong>palmitoyl CoA</strong>, the <strong>end </strong>product of <strong>fatty acid synthesis</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dephosphorylation of Acetyl CoA carboxylase </strong>is effected by <strong>protein phosphatase 1</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: CPS&ndash;I</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Carbamoyl phosphate synthetase I</strong> is an enzyme in the <strong>urea cycle, </strong>which may have <strong>increased </strong>activity during<strong> fasting</strong> due to the breakdown of<strong> amino acids for gluconeogenesis</strong>, resulting in <strong>excess nitrogen</strong> that needs to be<strong> excreted as urea.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Hormone-sensitive lipase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This enzyme is responsible for<strong> breaking down stored triglycerides </strong>in adipose tissue into <strong>free</strong> <strong>fatty acids and glycerol</strong>, which is <strong>upregulated</strong> during <strong>fasting to provide energy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Glycogen Phosphorylase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This enzyme <strong>breaks down glycogen</strong> into <strong>glucose-1-phosphate</strong>, which is then converted to <strong>glucose-6-phosphate for gluconeogenesis</strong> or <strong>energy production,</strong> and is thus <strong>upregulated</strong> during <strong>fasting.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>During fasting</strong>, the body <strong>downregulates </strong>enzymes involved in <strong>synthesizing storage </strong>compounds, such as <strong>acetyl CoA carboxylase, </strong>while <strong>upregulating enzymes</strong> that <strong>facilitate</strong> the mobilization of<strong> stored nutrients, </strong>like<strong> hormone-sensitive lipase</strong> and <strong>glycogen phosphorylase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 238</span></strong></span></span></p>",
      "correct_choice_id": 36246,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9042,
      "choices": [
        {
          "id": 36135,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Facilitated diffusion&nbsp;</span></span></span></p>"
        },
        {
          "id": 36136,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pinocytosis</span></span></span></p>"
        },
        {
          "id": 36137,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phagocytosis</span></span></span></p>"
        },
        {
          "id": 36138,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Receptor-mediated endocytosis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In an experiment, a team of scientists incubates liver cells at 0&deg;C and treats them with trypsin to digest surface receptors. The temperature is then increased to 37&deg;C, and radioactive LDL is introduced to the culture. Subsequently, the labelled LDL is found inside the liver cells. What is the process responsible for the internalization of LDL called?</span></span></span></p>",
      "unique_key": "Q9055737",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924665,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Receptor-mediated endocytosis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> LDL</strong> is taken up by<strong> peripheral tissues</strong> in the body by<strong> receptor-mediated endocytosis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>LDL receptors </strong>are<strong> located </strong>in specialized regions called <strong>clathrin coated pits. ​​Binding of LDL to the apo-B100 receptor </strong>by <strong>apo B100</strong> &rarr; the<strong> receptor-LDL complex </strong>is internalized by <strong>endocytosis</strong> &rarr; <strong>endosome vesicle fuses</strong> with <strong>lysosomes </strong>&rarr; <strong>receptor</strong> is <strong>recycled and returns</strong> to the <strong>cell surface </strong>and <strong>LDL particle + apoproteins + cholesterol ester</strong> are <strong>hydrolyzed </strong>by <strong>lysosomal hydrolases</strong> &rarr; forms<strong> fatty acids and free cholesterol.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Facilitated diffusion:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Is the transport of<strong> low-permeability molecules</strong> with the aid of a <strong>carrier protein.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Pinocytosis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uptake of <strong>small molecules in solution</strong>, is <strong>receptor &ndash;independent.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Phagocytosis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Process by which <strong>cells</strong> such as<strong> macrophages and neutrophils engulf large particles.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Receptor-mediated endocytosis</strong> is the <strong>specific and efficient</strong> mechanism by which <strong>LDL is internalized by liver cells,</strong> involving the interaction of<strong> LDL with cell surface LDL receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 257-258.</span></strong></span></span></p>",
      "correct_choice_id": 36138,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8947,
      "choices": [
        {
          "id": 35755,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiolipin</span></span></span></p>"
        },
        {
          "id": 35756,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dipalmitoyl phosphatidyl choline</span></span></span></p>"
        },
        {
          "id": 35757,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidyl ethanolamine</span></span></span></p>"
        },
        {
          "id": 35758,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidyl inositol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a neonatal intensive care unit at a research-focused hospital in India, a preterm newborn is admitted with signs of respiratory distress. The baby&#39;s mother had a complicated pregnancy, which led to early labor. The neonatologist considers the biochemical aspects that could be contributing to the baby&#39;s condition, specifically focusing on the surfactant composition in the baby&rsquo;s lungs. A deficiency in one of the surfactant components is suspected.&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which lipid component could be deficient in this preterm newborn, contributing to respiratory distress?</span></span></span></p>",
      "unique_key": "Q4434814",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924681,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dipalmitoyl phosphatidyl choline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> major</strong> lipid of<strong> lung surfactant</strong> is produced by <strong>type II alveolar cells.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Surfactant reduces surface tension</strong> of the<strong> aqueous layer of lung</strong> and <strong>prevents collapse of lung alveoli. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Constituents of surfactants:<strong> Dipalmitoyl phosphatidylcholine (DPPC)</strong> or <strong>dipalmitoyl lecithin (DPL), phosphatidyl glycerol,</strong> <strong>cholesterol and surfactant proteins A, B and C. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During fetal life,<strong> lung synthesizes sphingomyelin</strong> before <strong>28th week of GA</strong> &amp; when <strong>fetus matures,</strong> <strong>more lecithin</strong> is <strong>produced. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> lecithin-sphingomyelin (LS) ratio </strong>of a<strong>mniotic fluid</strong> is an index of <strong>fetal maturity. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the ratio is<strong> 2</strong>, it indicates <strong>full lung maturity. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Premature infants </strong>have a<strong> higher incidence of RDS </strong>because the<strong> immature lungs</strong> <strong>do not synthesize</strong> enough<strong> DPL. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cardiolipin:</strong> or <strong>Di phosphatidylglycerol </strong>is a major lipid of <strong>mitochondrial membrane</strong> and extracted from <strong>myocardium.</strong> <strong>Decreased cardiolipin level </strong>results in<strong> mitochondrial dysfunction, heart failure, hypothyroidism, and myopathies. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phosphatidyl ethanolamine: </strong>or<strong> Cephalin</strong><strong> </strong>is found in <strong>bio membranes</strong> and possess <strong>amphipathic</strong> properties.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phosphatidyl inositol: </strong>or<strong> PIP2</strong><strong> </strong>is present in <strong>bio membranes </strong>and plays important role in <strong>mediation of hormone action</strong> on <strong>bio membranes</strong> and also <strong>acts as a second messenger.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dipalmitoyl phosphatidylcholine (DPPC)</strong> is the major component of <strong>lung surfactant</strong>, which <strong>reduces surface tension</strong> in the<strong> alveoli,</strong> <strong>preventing collapse during exhalation</strong>. In <strong>preterm babies,</strong> <strong>surfactant</strong> production can be <strong>insufficient</strong>, leading to <strong>respiratory distress</strong> <strong>syndrome (RDS).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e :&nbsp; p 216 , Lippincott 7/e : P 204</span></strong></span></span></p>",
      "correct_choice_id": 35756,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8954,
      "choices": [
        {
          "id": 35783,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Gaucher’s disease</span></p>"
        },
        {
          "id": 35784,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Niemann Pick disease</span></p>"
        },
        {
          "id": 35785,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Tay-Sachs disease</span></p>"
        },
        {
          "id": 35786,
          "text": "<p><span style=\"font-size:12pt;\">Sandhoff's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A pediatrician evaluating a 6-month-old girl brought in by her mother. The baby has a history of repeated infections, fever, vomiting, and one seizure episode. There's a significant family history: an elder brother passed away at 3 years old from an undiagnosed condition. The baby appears lethargic and hypotonic, with bilateral nystagmus and a cherry red spot visible in both eyes. A blood examination reveals a decreased level of Hexosaminidase A enzyme, prompting the pediatrician to consider a genetic metabolic disorder. What is the most probable diagnosis for this baby?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/2_8cdDTT6.jpg\" alt=\"\" width=\"202\" height=\"152\"></p>",
      "unique_key": "Q9509446",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924686,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Tay-Sachs disease</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">It is a sphingolipidoses or lipid storage disease, due to deficiency of the enzyme Hexosaminidase A.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">C/F: Mental retardation, Cherry red spot in the macula and progressive deterioration. Death by 3–4 years</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong>:</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A: Gaucher’s disease type 1</strong>:&nbsp;Due to deficiency of beta-glucocerebrosidase, C/F: Enlarged liver and spleen, erosion of long bones, no mental retardation, no cherry red spot&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B: Niemann Pick disease</strong>:&nbsp;Due to deficiency of Sphingomyelinase. C/F: Mental retardation, blindness, muscular weakness, hepatosplenomegaly with Cherry red spot in macula. Death by 2 years of age.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D: Sandhoff’s disease</strong>:&nbsp;Due to deficiency of Hexosaminidase A and B, c/f: Neurological deficit and MR with cherry red spot.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Tay-Sachs disease is a genetic disorder characterized by the absence or insufficient activity of an enzyme called Hexosaminidase A, leading to the accumulation of GM2 ganglioside within lysosomes, causing progressive neurological damage.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Ref: Harper 30/e: p 68,251.</span></p>",
      "correct_choice_id": 35785,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7697,
      "choices": [
        {
          "id": 30756,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3 BPG is an intermediate of Gluconeogenesis</span></span></span></p>"
        },
        {
          "id": 30757,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Binding of 2,3 BPG decreases the affinity of Hb to O2 and shifts the ODC to right</span></span></span></p>"
        },
        {
          "id": 30758,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Binding of 2,3 BPG stabilises the R state</span></span></span></p>"
        },
        {
          "id": 30759,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3 BPG has increased interaction with HbF</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true regarding the interaction of hemoglobin with 2, 3-BPG</span></span></span></p>",
      "unique_key": "Q9882383",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924647,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Binding of 2,3 BPG decreases the affinity of Hb to O2 and shifts the ODC to right&nbsp;</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interaction of Hemoglobin with 2, 3 BPG</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2, 3 BPG</strong> is an <strong>intermediate of Glycolysis</strong> synthesized with the help of <strong>2, 3 BPG Shunt or Rapoport Luebering Cycle. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Hemoglobin tetramer </strong>binds to <strong>one mol of 2,3 BPG</strong> in the central cavity formed by <strong>four subunits.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2,3 BPG</strong> forms <strong>salt bridges</strong> with a<strong> terminal amino group of both &beta; globin chain </strong>via, <strong>Valine, Lysine and Histidine.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Binding of <strong>2,3 BPG decreases the affinity of Hb to Oxygen</strong>, by <strong>stabilizing the T state</strong> and shifts the<strong> ODC to right.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2, 3 BPG</strong> has <strong>decreased interaction with HbF</strong> as histidine forms <strong>salt bridges </strong>with <strong>2,3 BPG is not </strong>present in<strong> &gamma; chain of HbF</strong> &rarr;<strong> Instead</strong> of <strong>Histidine</strong> it is <strong>Serine, so 2,3 BPG </strong>has <strong>less interaction </strong>with <strong>Fetal Hb</strong> &rarr; accounts for <strong>high affinity of HbF</strong> towards <strong>Oxygen.</strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture18.jpg\" style=\"height:277px; width:700px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: 2, 3-BPG is an intermediate of gluconeogenesis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>incorrect.</strong> <strong>2, 3-BPG </strong>is formed from <strong>1,3-bisphosphoglycerate</strong> during<strong> glycolysis, not gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Binding of 2,3-BPG stabilizes the R state:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is<strong> incorrect.</strong> <strong>2, 3-BPG </strong>binds to and stabilizes the <strong>T (tense) state of Hb</strong>,<strong> not</strong> the<strong> R (relaxed) state</strong>, which has a <strong>higher affinity for oxygen.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2, 3-BPG has increased interaction with HbF:</strong> This is <strong>incorrect</strong>. <strong>HbF</strong> has a <strong>lower affinity for 2, 3-BPG </strong>than <strong>adult hemoglobin</strong> (HbA), which contributes to<strong> its higher affinity for oxygen</strong>, <strong>facilitating oxygen </strong>transfer from the <strong>mother to the fetus.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2, 3-BPG</strong> is a <strong>metabolite </strong>in the <strong>glycolytic pathway</strong> that binds to <strong>deoxyhemoglobin</strong> (<strong>Hb</strong> in the<strong> T or tense state)</strong> and <strong>stabilizes it</strong>, which <strong>decreases</strong> the <strong>oxygen affinity of Hb</strong>. This <strong>interaction</strong> is crucial for the <strong>release of O2 in tissues. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Binding of <strong>2, 3-BPG to Hb </strong>thus<strong> facilitates the delivery of oxygen</strong> to tissues by <strong>promoting the release of oxygen </strong>from <strong>Hb</strong>, which is reflected as a <strong>rightward shift in the ODC.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 288.</span></strong></span></span></p>",
      "correct_choice_id": 30757,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9097,
      "choices": [
        {
          "id": 36355,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphate dehydrogenase</span></span></span></p>"
        },
        {
          "id": 36356,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6-phosphogluconate dehydrogenase</span></span></span></p>"
        },
        {
          "id": 36357,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytoplasmic malate dehydrogenase</span></span></span></p>"
        },
        {
          "id": 36358,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malic enzyme</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sources of NADPH for fatty acid synthesis include all the following reactions, except:</span></span></span></p>",
      "unique_key": "Q2807703",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924644,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytoplasmic malate dehydrogenase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This <strong>enzyme converts oxaloacetate to malate</strong> &amp;<strong> utilizes one NADH</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> co-enzyme </strong>utilized for <strong>de novo synthesis of fatty acid</strong> is <strong>NADPH. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>sources </strong>of&nbsp; <strong>NADPH for fatty acid synthesis </strong>are:</span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pentose Phosphate Pathway</strong> (<strong>Glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase).</strong></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Malic enzyme</strong> (Converts<strong> Malate to Pyruvate</strong>)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Glucose-6-phosphate dehydrogenase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This enzyme is the <strong>first in the pentose phosphate pathway </strong>and is a<strong> major source </strong>of <strong>NADPH for fatty acid synthesis</strong> by oxidizing<strong> glucose-6-phosphate to 6-phosphogluconolactone.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: 6-phosphogluconate dehydrogenase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Also part of the<strong> pentose phosphate pathway,</strong> this enzyme further contributes to <strong>NADPH production </strong>by oxidizing<strong> 6-phosphogluconate to ribulose-5-phosphate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Malic enzyme</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This enzyme catalyzes the<strong> decarboxylation of malate to pyruvate,</strong> producing <strong>NADPH </strong>in the process, and serves as an <strong>additional source of NADPH for fatty acid synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cytoplasmic malate dehydrogenase </strong>is<strong> not</strong> a source of<strong> NADPH for fatty acid synthesis,</strong> unlike <strong>glucose-6-phosphate dehydrogenase</strong>, <strong>6-phosphogluconate dehydrogenase</strong>, and the <strong>malic enzyme,</strong> which all contribute to<strong> NADPH production</strong> in the<strong> cytoplasm </strong>for <strong>biosynthetic </strong>processes such as<strong> fatty acid synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 159.</span></strong></span></span></p>",
      "correct_choice_id": 36357,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9059,
      "choices": [
        {
          "id": 36203,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ascorbic acid</span></span></span></p>"
        },
        {
          "id": 36204,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Folic acid </span></span></span></p>"
        },
        {
          "id": 36205,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arachidonic acid</span></span></span></p>"
        },
        {
          "id": 36206,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linoleic acid</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man with abetalipoproteinemia presents with an abnormal blood picture showing acanthocytes, alongside symptoms of hyperkeratosis, acrodermatitis, and hypercholesterolemia. Considering the pathophysiology of abetalipoproteinemia and the patient&#39;s symptoms, the abnormal red cell morphology and associated clinical manifestations are most likely due to the malabsorption of which essential nutrient?</span></span></span></p>",
      "unique_key": "Q8880875",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924672,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linoleic acid</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>genetic defect</strong> might result in <strong>malabsorption of two fatty acids</strong> given in the options, but <strong>only linoleic acid </strong>is strictly <strong>essential in the diet (EFA). </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Linoleic acid and linolenic acid cannot</strong> be synthesized in the<strong> body </strong>and have to be <strong>provided </strong>only in the<strong> food,</strong> so they are <strong>essential fatty acids. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Arachidonic acid </strong>can be formed from <strong>linoleic acid, </strong>if the<strong> dietary supply of it is sufficient. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ABETALIPOPROTEINEMIA:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All <strong>apo-B </strong>containing<strong> lipoproteins </strong>are <strong>decreased </strong>due to<strong> defect in microsomal triglyceride transfer protein </strong>&rarr; <strong>TAG</strong> is <strong>not</strong> incorporated into <strong>VLDL and chylomicrons </strong>&rarr;<strong> absence of LDL</strong> and<strong> no</strong> absorption of<strong> Fat-soluble vitamins</strong> (causing <strong>mental</strong> <strong>and physical retardation)</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low Serum triglycerides, cholesterol and phospholipids.</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Blindness</strong> due to <strong>degenerative </strong>changes in<strong> retina. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Erythrocytes</strong> have <strong>spiny projections (acanthocytes)</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Ascorbic acid and (B) Folic acid:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absorption of<strong> water-soluble vitamins</strong> such as <strong>ascorbate and folate</strong> are <strong>not affected.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Arachidonic acid:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to the <strong>genetic defect</strong>, malabsorption of <strong>arachidonic acid is also affected </strong>but it&rsquo;s<strong> not an EFA</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Abetalipoproteinemia </strong>is a disorder characterized by the<strong> malabsorption and deficiency of fat-soluble vitamins</strong> and <strong>essential fatty</strong> <strong>acids</strong>, due to the<strong> inability </strong>to properly<strong> synthesize</strong> and <strong>secrete apolipoprotein B-containing lipoproteins.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Linoleic acid</strong> is a <strong>polyunsaturated fatty acid </strong>crucial for maintaining <strong>membrane integrity and function, </strong>including that of <strong>red blood</strong> <strong>cells. </strong>The<strong> deficiency in linoleic acid disrupts</strong> normal <strong>membrane structure</strong>,<strong> leading </strong>to the formation of <strong>acanthocytes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 6/e: p 182, 363.</span></strong></span></span></p>",
      "correct_choice_id": 36206,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7662,
      "choices": [
        {
          "id": 30616,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Belong to heat shock Proteins</span></span></span></p>"
        },
        {
          "id": 30617,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Present from bacteria to human</span></span></span></p>"
        },
        {
          "id": 30618,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ubiquitin is the most important chaperones</span></span></span></p>"
        },
        {
          "id": 30619,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also known as Stress Proteins</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A graduate student is preparing a presentation on protein folding and the role of molecular chaperones in maintaining cellular protein homeostasis. While researching, the student encounters various facts about chaperones but realizes one of the statements they&#39;ve noted is incorrect. Which of the following statements about chaperones is FALSE?</span></span></span></p>",
      "unique_key": "Q6760312",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924678,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ubiquitin is the most important chaperones</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ubiquitin</strong> is <strong>not</strong> a <strong>chaperone</strong> but a small regulatory protein that is involved in<strong> ubiquitination, </strong>a process that <strong>tags proteins</strong> for <strong>degradation</strong> by the <strong>proteasome. Chaperones,</strong> on the other hand, assist in the<strong> correct folding of proteins</strong> and the prevention of <strong>misfolded protein aggregation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note - <strong>Ubiquitin </strong>is the <strong>key</strong> molecule of <strong>protein degradation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Many chaperones</strong> do <strong>belong</strong> to the family of <strong>heat shock proteins (HSPs)</strong>, which are <strong>upregulated </strong>in response to <strong>stress</strong> to <strong>protect cells</strong> by <strong>preventing protein aggregation </strong>and assisting in <strong>protein refolding. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Chaperones</strong> are <strong>ubiquitous</strong> and are <strong>found in organisms</strong> ranging from <strong>bacteria to humans, </strong>playing essential roles in <strong>protein</strong> <strong>folding and maintenance.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Chaperones</strong> are often referred to as <strong>stress proteins</strong> due to their<strong> upregulation in response </strong>to <strong>cellular stress</strong> and their role in<strong> protecting cells by stabilizing proteins and complexes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Some Properties of Chaperone Proteins:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Present in a <strong>wide range of species from bacteria to humans</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Many are <strong>heat shock proteins (Hsp) </strong>and are known as<strong> stress proteins.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Some are<strong> inducible</strong> by conditions which cause <strong>unfolding of newly synthesized proteins </strong>(e.g. <strong>elevated temperature </strong>and various chemicals).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They <strong>bind</strong> to predominantly <strong>hydrophobic</strong> regions of<strong> unfolded proteins</strong> thus <strong>preventing their aggregation.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They<strong> act</strong> as a<strong> quality control </strong>or <strong>editing</strong> mechanism for <strong>detecting misfolded or defective proteins.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Most chaperones</strong> have associated<strong> ATPase activity, with ATP or ADP</strong> being involved in the <strong>protein-chaperone interaction.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Found in various <strong>cellular compartments</strong> such as<strong> cytosol, mitochondria, and the lumen of the endoplasmic reticulum.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 609.</span></span></strong></p>",
      "correct_choice_id": 30618,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8948,
      "choices": [
        {
          "id": 35759,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are right, but R is not the Correct explanation of A</span></span></span></p>"
        },
        {
          "id": 35760,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong </span></span></span></p>"
        },
        {
          "id": 35761,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is wrong but R is a right statement</span></span></span></p>"
        },
        {
          "id": 35762,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right, and R is a correct explanation of A</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A)</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>:</strong> Niemann-Pick disease is a glycogen storage disease characterized by mental retardation, organomegaly, etc.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><u>Reasoning (R)</u>: </strong>This is due to deficiency of enzyme hexosaminidase A.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choose the appropriate response.</span></span></span></p>",
      "unique_key": "Q9129312",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924682,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Niemann-Pick disease</strong> is a <strong>sphingolipidoses </strong>due to <strong>deficiency</strong> of the enzyme <strong>Sphingomyelinase </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipid accumulating</strong> - <strong>Sphingomyelin</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F: <strong>Enlarged liver and spleen, mental retardation</strong> and highly <strong>fatal in early life</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Niemann-Pick disease </strong>is <strong>not </strong>a <strong>glycogen storage disease;</strong> a type of <strong>lysosomal storage disorder</strong> characterized by the <strong>accumulation</strong> of <strong>sphingomyelin</strong> due to the <strong>deficiency of the enzyme sphingomyelinase</strong>. This leads to symptoms such as <strong>mental retardation </strong>and <strong>organomegaly. Hexosaminidase A deficiency, </strong>on the <strong>other hand,</strong> causes <strong>Tay-Sachs disease,</strong> <strong>not</strong> Niemann-Pick disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e page 251</span></strong></span></span></p>",
      "correct_choice_id": 35760,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7633,
      "choices": [
        {
          "id": 30500,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glutathione reductase</span></span></span></p>"
        },
        {
          "id": 30501,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glutathione peroxidase</span></span></span></p>"
        },
        {
          "id": 30502,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioredoxin peroxidase</span></span></span></p>"
        },
        {
          "id": 30503,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioredoxin oxidase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which enzyme is known to contain the amino acid selenocysteine?</span></span></span></p>",
      "unique_key": "Q4769660",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924664,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glutathione peroxidase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glutathione peroxidase </strong>is an <strong>enzyme </strong>that contains the rare <strong>amino acid selenocysteine </strong>at <strong>its active site</strong>. This <strong>enzyme </strong>is crucial for <strong>reducing lipid hydroperoxides </strong>to their corresponding <strong>alcohols </strong>and for <strong>reducing free hydrogen peroxide </strong>to <strong>water</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Glutathione reductase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - This enzyme <strong>does not </strong>contain <strong>selenocysteine</strong>; it catalyzes the <strong>reduction </strong>of <strong>glutathione disulfide </strong>to the<strong> sulfhydryl form glutathione.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Thioredoxin peroxidase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Also</strong> known as<strong> peroxiredoxins,</strong> these <strong>do not </strong>typically contain <strong>selenocysteine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Thioredoxin oxidase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - This is <strong>not </strong>a commonly <strong>recognized </strong>enzyme with <strong>selenocysteine</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Selenocysteine (SeCys) </strong>is seen at the <strong>active site </strong>of the following enzymes: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioredoxin reductase</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glutathione peroxidase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, which scavenges peroxides</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deiodinase </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">that removes iodine from thyroxine to make triiodothyronine </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Selenoprotein P</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, a glycoprotein seen in mammalian blood</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e p 215.</span></span></strong></p>",
      "correct_choice_id": 30501,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9053,
      "choices": [
        {
          "id": 36179,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo B-100</span></span></span></p>"
        },
        {
          "id": 36180,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo B-48</span></span></span></p>"
        },
        {
          "id": 36181,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo A-II</span></span></span></p>"
        },
        {
          "id": 36182,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo A-I</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the listed apolipoproteins, which one serves as an activator for Lecithin Cholesterol Acyltransferase (LCAT), an enzyme critical in the process of cholesterol esterification within high-density lipoprotein (HDL) particles?</span></span></span></p>",
      "unique_key": "Q6897969",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924669,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo A-I</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apo A-I </strong>is the <strong>primary protein </strong>component of <strong>HDL </strong>particles and serves as an <strong>activator </strong>for <strong>LCAT</strong>. LCAT plays a crucial role in the <strong>esterification of free cholesterol </strong>on the surface of <strong>HDL particles</strong>, facilitating the <strong>maturation of HDL </strong>and its role in <strong>reverse cholesterol transport </strong>from <strong>peripheral tissues </strong>back to the <strong>liver for excretion</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Apo B-100</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This <strong>apolipoprotein </strong>is the primary protein component of <strong>low-density lipoprotein (LDL) </strong>and<strong> very low-density lipoprotein (VLDL), not </strong>associated with <strong>activating LCAT</strong>. Its primary role is in the <strong>structural integrity </strong>of these particles and in mediating their <strong>interaction with LDL receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Apo B-48</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Apo B-48 is found in <strong>chylomicrons and chylomicron remnants</strong>. It is essential for the<strong> assembly and secretion </strong>of these <strong>lipoproteins </strong>in the <strong>intestines </strong>but <strong>does not </strong>play a role in <strong>activating LCAT</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Apo A-II</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Although Apo A-II is also a<strong> component of HDL,</strong> unlike Apo A-I, it is <strong>not </strong>known to <strong>activate LCAT</strong>. Its precise function is <strong>not </strong>as well understood as that of <strong>Apo A-I</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>INHIBITOR</strong> OF ENZYMES: <strong>CI</strong> inhibits <strong>CETP</strong>, <strong>A-II, C-III</strong> inhibits <strong>LPL </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>ACTIVATOR</strong> OF ENZYMES:<strong> </strong>&nbsp;<strong>A-I</strong> activates <strong>LCAT</strong>, <strong>C-I, II</strong> activates<strong> LPL</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-101017.png\" style=\"height:435px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/ed, pg -272.</span></strong></span></span></p>",
      "correct_choice_id": 36182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7670,
      "choices": [
        {
          "id": 30648,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sulfhydryl group</span></span></p>"
        },
        {
          "id": 30649,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indole group</span></span></span></p>"
        },
        {
          "id": 30650,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenyl group </span></span></span></p>"
        },
        {
          "id": 30651,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Imidazole group</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which group among the following is responsible for buffering activity of proteins at physiological pH?</span></span></span></p>",
      "unique_key": "Q1472496",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924683,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Imidazole group</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>imidazole group</strong>, which is<strong> part </strong>of the <strong>histidine amino acid side chain, </strong>has significant <strong>buffering capacity at physiological pH</strong> (around<strong> 7.4</strong>). This is because the<strong> pKa of the imidazole group</strong> is close to the <strong>physiological pH,</strong> allowing it to <strong>effectively donate</strong> or <strong>accept protons,</strong> thereby contributing to <strong>buffering.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Sulfhydryl group</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Present in cysteine</strong>, important for <strong>forming disulfide bonds,</strong> but <strong>not </strong>primarily known for <strong>buffering. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Indole group</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - F<strong>ound in tryptophan</strong>, contributes to the <strong>protein&#39;s structural and functional</strong> aspects but <strong>lacks</strong> significant <strong>buffering capacity. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Phenyl group </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- <strong>Part of phenylalanine</strong>, contributes to <strong>hydrophobic interactions </strong>in<strong> proteins</strong> but does<strong> not</strong> have a<strong> buffering</strong> role.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only<strong> amino acid </strong>whose <strong>pKa value (6.1) </strong>is nearby <strong>physiological pH (7.4)</strong> is <strong>Histidine</strong> (<strong>Imidazole group</strong>), due to which it has <strong>buffering</strong> <strong>activity </strong>at <strong>physiological pH.</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture28.jpg\" style=\"height:318px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: p 28.</span></strong></span></span></p>",
      "correct_choice_id": 30651,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7683,
      "choices": [
        {
          "id": 30700,
          "text": "<p><span style=\"font-size:12.0pt;\">RFLP result from a single base change</span></p>"
        },
        {
          "id": 30701,
          "text": "<p><span style=\"font-size:12.0pt;\">Single nucleotide change results in change of Glutamate to Valine</span></p>"
        },
        {
          "id": 30702,
          "text": "<p><span style=\"font-size:12.0pt;\">HbS confers resistance against malaria in heterozygotes</span></p>"
        },
        {
          "id": 30703,
          "text": "<p><span style=\"font-size:12.0pt;\">‘Sticky patch’ is generated as a result of replacement of a nonpolar residue with a polar residue in Sickle Cell Anemia (HbS)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 3.5-year-old girl of Arabian descent presents to the clinic with severe anemia, thrombocytopenia, leukocytosis, and elevated ESR. The history provided by her parents includes fever, cough, pallor, weakness, and tachypnea. On examination, hepatomegaly is noted. Following diagnostic evaluations, sickle cell anemia (SCA) is diagnosed. Based on the information provided, which of the following statements about SCA is false?</span></p>",
      "unique_key": "Q2616134",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924640,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) ‘Sticky patch’ is generated as a result of replacement of a nonpolar residue with a polar residue in Sickle Cell Anemia (HbS) — this is False.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In <strong>sickle cell anemia</strong>, the amino acid substitution involves replacing a <strong>polar residue Glutamate&nbsp;</strong>with a <strong>nonpolar residue (valine)</strong> at the 6th position of the β-globin chain.</span></p><p><span style=\"font-size:12.0pt;\">This substitution creates a <strong>hydrophobic “sticky patch”</strong> on the surface of the deoxygenated hemoglobin S (HbS) molecule. These hydrophobic patches interact abnormally with each other, leading to <strong>polymerization of HbS</strong> inside red cells, which causes the characteristic \"sickling\" shape of RBCs under hypoxic conditions.</span></p><p><span style=\"font-size:12.0pt;\">So the false statement is that the “sticky patch” arises from a <strong>nonpolar → polar substitution</strong> — the reality is the opposite:</span><br><span style=\"font-size:12.0pt;\">→ It’s a <strong>polar (glutamate) → nonpolar (valine)</strong> substitution.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A) RFLP result from a single base change:</strong></span><br><span style=\"font-size:12.0pt;\">Correct — The sickle cell mutation involves a single nucleotide change (<strong>A → T</strong> at the 6th codon), which eliminates a restriction enzyme site. This difference can be detected using <strong>Restriction Fragment Length Polymorphism (RFLP)</strong> analysis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B) Single nucleotide change results in change of Glutamate to Valine:</strong></span><br><span style=\"font-size:12.0pt;\"><strong>Correction:</strong> this statement is <strong>Correct</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C) HbS confers resistance against malaria in heterozygotes:</strong></span><br><span style=\"font-size:12.0pt;\">Correct — Heterozygotes for the HbS gene (sickle cell trait) are relatively protected against <strong>Plasmodium falciparum malaria</strong>, explaining its evolutionary persistence in malaria-endemic regions.</span><br><br>&nbsp;</li></ul><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In <strong>Sickle Cell Anemia (SCA)</strong>, a single point mutation (A → T) at the 6th codon of the <strong>β-globin gene</strong> results in the substitution of <strong>Glutamate (polar)</strong> with <strong>valine (nonpolar)</strong>. This creates a hydrophobic site (\"sticky patch\") on deoxygenated HbS, triggering polymerization, red cell sickling, hemolysis, and vaso-occlusive complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ref: Harper 30/e p 417, 693.</span></p>",
      "correct_choice_id": 30703,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8951,
      "choices": [
        {
          "id": 35771,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasmalogens</span></span></span></p>"
        },
        {
          "id": 35772,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiolipin</span></span></span></p>"
        },
        {
          "id": 35773,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidylinositol</span></span></span></p>"
        },
        {
          "id": 35774,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lecithin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A medical researcher is exploring the immunological properties of different phospholipids. During a study designed to understand the role of phospholipids in autoimmune disorders, they isolate various phospholipids from cell membranes and assess their potential antigenic properties.&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following phospholipids possesses antigenic properties?</span></span></span></p>",
      "unique_key": "Q5881502",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924684,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiolipin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is the <strong>major lipid</strong> of <strong>Inner Mitochondrial Membranes </strong>and is the only <strong>Phospholipid </strong>which possesses <strong>antigenicity.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is recognized by<strong> antibodies raised against Treponema pallidum,</strong> which causes <strong>syphilis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Decreased levels of cardiolipin</strong> or<strong> alteration</strong> in its<strong> structure </strong>or<strong> metabolism </strong>cause <strong>mitochondrial dysfunction.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Plasmalogens </strong>are found in<strong> bio membranes in brain and muscle.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Phosphatidylinositol</strong> acts as a <strong>second messenger </strong>and plays a vital role in the <strong>mediation of hormone</strong> action on bio membranes.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dipalmitoyl Lecithin / Di Palmitoyl Phosphatidyl Choline </strong>is the most <strong>abundant phospholipid of cell membrane,</strong> largest <strong>body store of choline</strong> and a major constituent of <strong>lung surfactant</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cardiolipin </strong>is a <strong>phospholipid</strong> that has <strong>antigenic properties </strong>and can be involved in <strong>autoimmune responses</strong>, such as in the case of <strong>anti-phospholipid syndrome.</strong> It is commonly associated with<strong> syphilis,</strong> where it is the <strong>reactive agent</strong> in the <strong>Wassermann test,</strong> and with<strong> lupus,</strong> where it is targeted by<strong> anti-cardiolipin antibodies.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 108</span></strong></span></span></p>",
      "correct_choice_id": 35772,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7672,
      "choices": [
        {
          "id": 30656,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Covalent</span></span></p>"
        },
        {
          "id": 30657,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peptide</span></span></span></p>"
        },
        {
          "id": 30658,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amide Bond</span></span></p>"
        },
        {
          "id": 30659,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a biochemistry tutorial, the discussion focuses on the various levels of protein structure and the types of bonds that stabilize each level. A key topic is the primary structure of proteins and the specific type of bond that links amino acids together in a polypeptide chain. Which type of bond is involved in the formation of the primary structure of a protein or polypeptide?</span></span></span></p>",
      "unique_key": "Q3924041",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924658,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> primary structure of a protein</strong> or <strong>polypeptide</strong> is formed through <strong>peptide bonds</strong>, which are a<strong> specific</strong> type of <strong>covalent bond.</strong> An <strong>amide bond </strong>is another term for a<strong> peptide bond</strong> when referring to<strong> its chemical nature</strong>. Therefore, <strong>all the options </strong>accurately describe the<strong> bond </strong>involved in forming the<strong> primary structure of proteins.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bonds responsible for protein structure</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Two types of bonds</strong> stabilize <strong>protein structure:</strong></span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<ol start=\"1\" style=\"list-style-type:lower-roman\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Covalent </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(<strong>Strong</strong>): - <strong>Peptide bonds</strong> (Amide bond), <strong>Disulfide bond </strong>(present in all types of protein structures)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-covalent (weak): </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hydrogen bond, hydrophobic interactions, electrostatic</strong> (or ionic or salt) bond, <strong>Vander Waals</strong> <strong>interactions</strong> (present in secondary, tertiary and quaternary protein structures)</span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture2.jpg\" style=\"height:562px; width:1000px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: p 34.</span></strong></span></span></p>",
      "correct_choice_id": 30659,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8952,
      "choices": [
        {
          "id": 35775,
          "text": "<p><span style=\"font-size:12.0pt;\">Tay-Sachs disease</span></p>"
        },
        {
          "id": 35776,
          "text": "<p><span style=\"font-size:12.0pt;\">Niemann-Pick disease</span></p>"
        },
        {
          "id": 35777,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaucher’s disease</span></p>"
        },
        {
          "id": 35778,
          "text": "<p><span style=\"font-size:12.0pt;\">GM 1 gangliosidoses</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following diseases is least likely to include neurological symptoms in its classic presentation?</span></p>",
      "unique_key": "Q5942082",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924685,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;Gaucher’s disease</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">It is a AR disorder.</span></p><p><span style=\"font-size:12.0pt;\">Due to deficiency of beta-glucocerebrosidase&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>C/</strong>F:</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Bony pain, pathological fracture</span></p><p><span style=\"font-size:12.0pt;\">No MR (as beta-glucosylceramide is present in extra neutral tissue)</span></p><p><span style=\"font-size:12.0pt;\">Hepatosplenomegaly present</span></p><p><span style=\"font-size:12.0pt;\">Large amounts of glucosylceramide accumulated in macrophages causing: Eccentric nucleus and Cytoplasm’s Crumpled tissue paper appearance&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong>:</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;Tay-Sachs disease</strong>: C/F: Neurological Symptoms, Mental retardation. Cherry red spot&nbsp;in the macula. Progressive deterioration No Hepatosplenomegaly.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B:&nbsp;Niemann-Pick disease</strong>: C/F:&nbsp; Severe CNS damage, mental retardation, hepatosplenomegaly, Cherry red spot in macula.&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D:&nbsp;GM1 gangliosidoses</strong>: C/F: Mental retardation, hepatomegaly, skeletal deformities. Angiokeratoma. Cherry red spot in the retina.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Gaucher's disease, particularly type 1, which is the most common form, does not usually present with neurological symptoms. This type is known as non-neuronopathic and primarily affects the spleen, liver, and bones.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Ref: DM Vasudevan 9/e: p 260, 261.</span></p>",
      "correct_choice_id": 35777,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7620,
      "choices": [
        {
          "id": 30448,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Point A represents the region where the amino acid is deprotonated.</span></span></span></p>"
        },
        {
          "id": 30449,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Point B represents a region of minimal buffering.</span></span></span></p>"
        },
        {
          "id": 30450,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Point C represents the region where the net charge on the amino acid is zero.</span></span></span></p>"
        },
        {
          "id": 30451,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Point D represents the pKa of the amino acid carboxyl group.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A researcher is analyzing the titration curve of a nonpolar amino acid as shown in the graph with points labeled A to D. Which of the following statements correctly interprets the designated regions on the curve?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture9.jpg\" style=\"height:161px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q6508013",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924656,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Point C represents the region where the net charge on the amino acid is zero.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Point C </strong>on a <strong>titration curve </strong>usually <strong>indicates </strong>the <strong>isoelectric point (pI) of an amino acid</strong>, where it has <strong>no net electric charge</strong>. This point is particularly <strong>useful</strong> in predicting the<strong> behavior of the amino acid </strong>under<strong> various pH </strong>conditions. At the<strong> isoelectric point</strong>, an <strong>amino acid neither moves</strong> towards the <strong>anode nor </strong>the <strong>cathode </strong>during<strong> electrophoresis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Point A represents the region where the amino acid is deprotonated:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>amino acid </strong>is <strong>fully protonated </strong>at <strong>Point A </strong>due to <strong>low pH </strong>and <strong>abundance of protons </strong>in the solvent. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Point B represents a region of minimal buffering &amp; Option D Point D represents the pK of the amino acid carboxyl group: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Point B </strong>represents a region of <strong>maximum buffering</strong>, as does <strong>Point D </strong>which is the <strong>pKa of amino group.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>amino acid </strong>could be <strong>lysine</strong>. <strong>C represents the isoelectric point</strong>, or <strong>pI, </strong>and as such is midway between<strong> pK1 and pK2 for a nonpolar amino acid</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lysine </strong>is a<strong> basic amino acid </strong>and has an<strong> ionizable side chain</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 7/e: p 6-9.</span></span></strong></p>",
      "correct_choice_id": 30450,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7611,
      "choices": [
        {
          "id": 30412,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aldehyde test</span></span></span></p>"
        },
        {
          "id": 30413,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Millon&rsquo;s test</span></span></span></p>"
        },
        {
          "id": 30414,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ninhydrin test</span></span></span></p>"
        },
        {
          "id": 30415,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biuret test</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following color reactions is most likely used to confirm the presence of tyrosine in the protein?</span></span></span></p>",
      "unique_key": "Q6404054",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924650,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Millon&rsquo;s test</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Millon&rsquo;s test </strong>is specifically designed to detect <strong>phenolic compounds</strong>, and it gives a <strong>positive result for tyrosine </strong>due to the presence of a <strong>phenol group </strong>in its side chain. When <strong>proteins containing tyrosine </strong>are treated with <strong>Millon&rsquo;s reagent </strong>(which contains <strong>mercuric nitrate</strong>), a<strong> red color </strong>develops, indicating the<strong> presence of tyrosine</strong>. This <strong>test is unique </strong>among the options for its<strong> specificity to tyrosine</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Aldehyde test -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This <strong>test </strong>is <strong>not </strong>specifically associated with the <strong>detection of tyrosine </strong>in proteins.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Ninhydrin test -&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>ninhydrin reacts </strong>with <strong>amino acids </strong>to produce a color change (typically <strong>blue or purple</strong>), it is <strong>not specific to tyrosine</strong>; it is more broadly <strong>used to detect free amino acids, </strong>especially <strong>proline and </strong>other <strong>secondary amines</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Biuret test -&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Biuret test is used to<strong> detect </strong>the presence of <strong>peptide bonds in proteins </strong>and is <strong>not </strong>specific for any particular <strong>amino acid</strong>, including<strong> tyrosine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The phenol group of <strong>phenylalanine and tyrosine </strong>containing proteins, when<strong> heated with mercuric sulfate </strong>in <strong>sulphuric acid and sodium nitrite </strong>form <strong>red coloured mercury phenolate.</strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture6.jpg\" style=\"height:487px; width:1000px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Done by<strong> Millon, 1812&ndash;1867.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chloride </strong>interferes with this <strong>reaction </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e p 31.</span></strong></span></span></p>",
      "correct_choice_id": 30413,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9064,
      "choices": [
        {
          "id": 36223,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are right but R is not the correct explanation of A</span></span></span></p>"
        },
        {
          "id": 36224,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is wrong but R is a right statement</span></span></span></p>"
        },
        {
          "id": 36225,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right, and R is a correct explanation of A</span></span></span></p>"
        },
        {
          "id": 36226,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A):</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In well-fed state, activity of acetyl CoA carboxylase activity is increased.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasoning (R):</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Citrate produced from acetyl CoA in well-fed state acts as an allosteric activator of acetyl CoA carboxylase:</span></span></span></p>",
      "unique_key": "Q6060131",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924676,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right, and R is a Correct explanation of A</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acetyl-CoA carboxylase</strong> is an <strong>allosteric enzyme</strong> and is activated by <strong>citrate, </strong>which <strong>increases </strong>in concentration in a <strong>well-fed state </strong>and is also an <strong>indicator of a plentiful supply of acetyl-CoA.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Citrate </strong>favours <strong>conversion </strong>of the enzyme from an <strong>inactive dimer to an active polymeric form</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture22_WBxHtRE.jpg\" style=\"height:339px; width:602px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inactivation </strong>is by <strong>phosphorylation </strong>of the enzyme and by<strong> long-chain acyl-CoA </strong>molecules such as <strong>palmitoyl CoA </strong>using <strong>feedback inhibition </strong>and <strong>inhibition </strong>of <strong>citrate transport from mitochondria to cytosol</strong>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acetyl CoA carboxylase </strong>is an enzyme crucial in <strong>fatty acid synthesis. </strong>In a <strong>well-fed state, </strong>the abundance of <strong>acetyl CoA </strong>leads to the production of <strong>citrate</strong>, which can be transported <strong>out </strong>of the <strong>mitochondria into the cytosol</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Citrate </strong>serves as an <strong>allosteric activator of acetyl CoA carboxylase</strong>, <strong>increasing </strong>its <strong>activity. </strong>This<strong> upregulation </strong>is consistent with the <strong>body&#39;s shift toward anabolic processes</strong>, like <strong>fatty acid synthesis</strong>, when there is a <strong>surplus of energy</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 237-238</span></strong></span></span></p>",
      "correct_choice_id": 36225,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9057,
      "choices": [
        {
          "id": 36195,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RNA alternate splicing</span></span></span></p>"
        },
        {
          "id": 36196,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RNA editing</span></span></span></p>"
        },
        {
          "id": 36197,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DNA editing</span></span></span></p>"
        },
        {
          "id": 36198,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RNA interference</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A molecular biologist is explaining to a group of students the unique process through which Apo B48 is produced in the body. This protein is essential for the formation of chylomicrons, which transport dietary lipids from the intestines to other parts of the body. By what mechanism is Apo B48 generated?</span></span></span></p>",
      "unique_key": "Q7156971",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924670,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RNA editing</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apo-B-48</strong> is the major<strong> apoprotein of chylomicrons. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is synthesized only in the<strong> intestinal cells. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apo-B100 and apo-B48 </strong>are products of the <strong>same gene</strong>, but in the intestine, the <strong>mRNA </strong>undergoes <strong>editing and </strong>so produces the <strong>B48 protein. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is named so because it is only <strong>40% of the size of B100.&nbsp;&nbsp; </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-103140.png\" style=\"height:296px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: RNA alternate splicing</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This process involves the<strong> removal or inclusion </strong>of segments of the <strong>pre-mRNA transcript</strong>, leading to the production of <strong>different mRNA variants </strong>and, consequently<strong>, different proteins from the same gene. </strong>However, it is<strong> not </strong>the mechanism by which <strong>Apo B48 </strong>is produced.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: DNA editing</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DNA editing refers to<strong> direct changes to the DNA sequence itself</strong>, which is <strong>not </strong>applicable in the <strong>case of Apo B48 production</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: RNA interference</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: RNA interference is a<strong> biological process </strong>in which <strong>RNA molecules inhibit gene expression or translation by neutralizing targeted mRNA molecules. </strong>It<strong> does not </strong>involve the production of <strong>Apo B48</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apo B48</strong> is generated through<strong> RNA editing, a post-transcriptional modification </strong>that alters the <strong>nucleotide </strong>sequence of the <strong>RNA</strong>, resulting in a <strong>shorter protein variant </strong>crucial for <strong>chylomicron formation in the intestines.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p226.</span></strong></span></span></p>",
      "correct_choice_id": 36196,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7625,
      "choices": [
        {
          "id": 30468,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tryptophan</span></span></span></p>"
        },
        {
          "id": 30469,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arginine</span></span></span></p>"
        },
        {
          "id": 30470,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guanine</span></span></span></p>"
        },
        {
          "id": 30471,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A biochemist is optimizing a protein assay by enhancing the protein&#39;s absorbance at 280 nm for better detection and quantification. The protein contains alanine, which does not contribute significantly to absorbance at this wavelength. The scientist is considering substituting alanine with another amino acid that naturally exhibits strong absorbance at 280 nm, which would increase the overall absorbance of the protein at this wavelength.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Replacing alanine with which amino acid will increase the protein&#39;s absorbance at 280 nm?</span></span></span></p>",
      "unique_key": "Q3190415",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924659,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tryptophan</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tryptophan </strong>has a <strong>strong </strong>absorbance at <strong>280 nm</strong> due to its <strong>aromatic ring structure</strong>, which allows it to <strong>absorb ultraviolet light effectively</strong>. This property is <strong>utilized</strong> in <strong>protein assays</strong>, such as <strong>spectrophotometry</strong>, to estimate the <strong>concentration of proteins based on their tryptophan </strong>(and also <strong>tyrosine</strong>) content.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u>Other Options:</u></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Arginine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - While arginine is an <strong>important amino acid</strong>, it <strong>does not </strong>have significant <strong>absorbance at 280 nm</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Guanine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - Guanine is a <strong>nucleic acid base</strong>, <strong>not an amino acid</strong>, and thus is <strong>not </strong>relevant in the context of <strong>protein absorbance</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Lysine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - Like <strong>arginine</strong>, <strong>lysine does not </strong>significantly <strong>absorb at 280 nm </strong>and would <strong>not increase </strong>the <strong>protein&#39;s absorbance </strong>at this wavelength.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Amino Acids </strong>which <strong>absorb 250&ndash;290 nm </strong>(<strong>Maximum at 280 nm</strong>) <strong>UV </strong>light are <strong>tryptophan, phenylalanine, and tyrosine</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maximum absorption </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">of </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">UV light</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is by</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Tryptophan.</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p 21, 22.</span></strong></span></span></p>",
      "correct_choice_id": 30468,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7692,
      "choices": [
        {
          "id": 30736,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilirubin UDP-glucuronosyltransferase</span></span></span></p>"
        },
        {
          "id": 30737,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ferrochelatase</span></span></span></p>"
        },
        {
          "id": 30738,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heme oxygenase </span></span></span></p>"
        },
        {
          "id": 30739,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&delta;-Aminolevulinic acid synthase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-year-old male child presents to the pediatric outpatient department with a history of recurrent gastrointestinal disturbances and lethargy over the past few weeks. Laboratory investigations reveal a microcytic, hypochromic anemia and elevated blood lead levels, suggestive of lead poisoning. Given this child&#39;s condition, which of the following enzymes would likely exhibit increased activity in the liver as a compensatory or pathophysiological response?</span></span></span></p>",
      "unique_key": "Q9687368",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924645,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) &delta; -Aminolevulinic acid synthase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This child is a case of <strong>acquired porphyria </strong>due to <strong>lead poisoning</strong>, as lead <strong>inhibits &delta; -aminolevulinic acid dehydratase </strong>and thereby <strong>heme synthesis. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So, the <strong>decrease in heme levels </strong>has 2 effects (i)<strong> derepresses &delta;-aminolevulinic acid synthase -1 (hepatic isozyme) &rarr; increase in its activity </strong>(ii)<strong> decreases the hemoglobin synthesis </strong>and results in <strong>anemia </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Bilirubin UDP-glucuronosyltransferase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme is involved in the <strong>conjugation of bilirubin</strong>, not directly affected in lead poisoning.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Ferrochelatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Lead poisoning </strong>actually <strong>inhibits ferrochelatase, decreasing its activity</strong>. <strong>Ferrochelatase </strong>catalyzes the <strong>insertion of iron </strong>into <strong>protoporphyrin IX </strong>to form <strong>heme</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Heme oxygenase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme catalyzes the <strong>degradation of heme to biliverdin, free iron, and carbon monoxide</strong>. It is<strong> not</strong> specifically <strong>upregulated </strong>in <strong>lead poisoning.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> effects of lead poisoning</strong> on the<strong> heme biosynthesis pathway,</strong> particularly the <strong>inhibition of specific enzymes like ALA dehydratase</strong> and<strong> ferrochelatase, </strong>leading to a <strong>compensatory increase</strong> in<strong> &delta;-ALAS activity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 326-327, 334.</span></span></strong></p>",
      "correct_choice_id": 30739,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8965,
      "choices": [
        {
          "id": 35827,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucocerebrosidase</span></span></span></p>"
        },
        {
          "id": 35828,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sphingomyelinase</span></span></span></p>"
        },
        {
          "id": 35829,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hexosaminidase A</span></span></span></p>"
        },
        {
          "id": 35830,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-galactosidase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old child is brought to the pediatric clinic by his parents, who report that he has been experiencing unusual fatigue, frequent bruising, and episodes of bone pain over the last few months. The child has also been less active than usual, preferring to sit rather than play with his peers. On examination, the pediatrician notes pallor, and palpation reveals an enlarged liver and spleen. A complete blood count confirms anemia and thrombocytopenia. A bone marrow biopsy is performed, and light microscopy of the sample shows cells with a &quot;crumpled tissue paper&quot; appearance. Given these findings, which enzyme defect is most likely responsible for this child&#39;s condition?</span></span></span></p>",
      "unique_key": "Q6130833",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924643,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucocerebrosidase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gaucher&rsquo;s Disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common <strong>Lysosomal Storage Disorder</strong> due to <strong>Glucocerebrosidase defect</strong> &rarr; accumulation of <strong>glucocerebroside</strong> in <strong>lysosomes. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F: <strong>No cherry red spot in the macula, No mental deterioration (Type I)</strong>, Haematological features: <strong>Pancytopenia,</strong> <strong>bleeding manifestation, Hepatosplenomegaly, Bone Pain and Pathological Fractures of long bones</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-ray<strong> Femur Erlenmeyer Flask Deformity</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bone Marrow Biopsy:&nbsp;</strong> <strong>Gaucher cell with Wrinkled paper appearance</strong>/<strong>crumpled tissue paper </strong>appearance.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Sphingomyelinase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Deficiency of sphingomyelinase </strong>is associated with <strong>Niemann-Pick disease</strong>, which also<strong> presents </strong>with <strong>hepatosplenomegaly</strong> but typically includes <strong>neurological symptoms </strong>due to the <strong>accumulation of sphingomyelin in neurons,</strong> which is <strong>not</strong> indicated in this<strong> scenario.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Hexosaminidase A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Deficiency in Hexosaminidase A enzyme</strong> is related to <strong>Tay-Sachs disease,</strong> which primarily presents with <strong>progressive neurological symptoms </strong>due to the accumulation of<strong> GM2 ganglioside</strong> in the <strong>neuronal cells,</strong> <strong>not</strong> the features described in the<strong> presented case.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Beta-galactosidase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A<strong> deficiency </strong>in this enzyme leads to<strong> GM1 gangliosidosis,</strong> which includes <strong>severe neurological</strong> <strong>impairment and skeletal abnormalities</strong> in its<strong> presentation, distinct from</strong> the scenario described.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>clinical presentation </strong>of <strong>Gaucher&#39;s disease</strong>, a <strong>lysosomal storage disorder</strong> caused by a <strong>deficiency </strong>of the enzyme <strong>glucocerebrosidase</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 260, 261</span></strong></span></span></p>",
      "correct_choice_id": 35827,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7622,
      "choices": [
        {
          "id": 30456,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glutamate to aspartate </span></span></span></p>"
        },
        {
          "id": 30457,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysine to arginine </span></span></span></p>"
        },
        {
          "id": 30458,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methionine to proline</span></span></span></p>"
        },
        {
          "id": 30459,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valine to alanine </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient has a point mutation at a specific site which results in disruption of the &alpha;-helical structure in a segment of the resultant mutant protein. The most likely change that can occur in the primary structure of the mutant protein is:</span></span></span></p>",
      "unique_key": "Q6791183",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924657,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methionine to proline</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Proline</strong>, because of its <strong>secondary amino group</strong>, is<strong> incompatible </strong>with an <strong>&alpha;-helix</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glutamate, aspartate, lysine, and arginine </strong>are <strong>charged amino acids </strong>and <strong>valine and alanine </strong>are<strong> non-polar amino acids</strong>. So, they are like for like replacements and are <strong>unlikely </strong>to cause any <strong>disruption of protein secondary structure</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u>Other Options:</u></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Glutamate to aspartate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Both </strong>are <strong>acidic amino acids </strong>with similar properties and <strong>would not </strong>typically <strong>disrupt an &alpha;-helix</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Lysine to arginine </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- <strong>Both </strong>are<strong> basic amino acids </strong>and are<strong> similarly structured, </strong>making it<strong> unlikely </strong>to <strong>disrupt the &alpha;-helix </strong>significantly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Valine to alanine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Both </strong>are <strong>small, nonpolar amino acids </strong>that<strong> fit </strong>well within an <strong>&alpha;-helix without causing disruption.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Proline </strong>is known as a <strong>helix breaker </strong>because its <strong>cyclic structure </strong>creates a <strong>fixed kink </strong>that can <strong>disrupt the &alpha;-helix&#39;s </strong>regular <strong>geometry</strong>. A substitution of<strong> methionine to proline </strong>in a protein&#39;s<strong> primary structure </strong>is likely to <strong>disrupt an &alpha;-helical segment</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 38.</span></span></strong></p>",
      "correct_choice_id": 30458,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7613,
      "choices": [
        {
          "id": 30420,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The molecule carries no net charge</span></span></span></p>"
        },
        {
          "id": 30421,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Solubility and buffering capacity will be maximum</span></span></span></p>"
        },
        {
          "id": 30422,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The buffering capacity of plasma proteins are mainly due to Histidine residue.</span></span></span></p>"
        },
        {
          "id": 30423,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is no mobility in an electric field</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about the isoelectric pH (pI) of a molecule is INCORRECT?</span></span></span></p>",
      "unique_key": "Q9287309",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924652,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Solubility and buffering capacity will be maximum</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At its <strong>isoelectric pH</strong>, a molecule (such as an <strong>amino acid or protein</strong>) carries <strong>no net electrical charge</strong>, leading to <strong>minimal solubility </strong>in <strong>aqueous solutions </strong>due to <strong>reduced electrostatic interactions </strong>with<strong> water molecules</strong>. <strong>Contrary to increasing solubility </strong>and <strong>buffering capacity</strong>,<strong> both </strong>are actually at their <strong>minimum at the isoelectric point </strong>because the molecule has<strong> no net charge </strong>to <strong>donate or accept protons </strong>readily, thus <strong>reducing its ability </strong>to <strong>act </strong>as a <strong>buffer</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: The molecule carries no net charge -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is<strong> correct</strong>. At the <strong>isoelectric </strong>point, the number of <strong>positive charges equals </strong>the number of <strong>negative charges</strong>, resulting in <strong>no net charge</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: The buffering capacity of plasma proteins is mainly due to Histidine residue -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is generally <strong>correct </strong>as <strong>histidine </strong>residues in<strong> proteins, </strong>such as those in <strong>plasma proteins</strong>, play a significant role in <strong>buffering </strong>due to the <strong>pKa of the histidine side chain </strong>being close to <strong>physiological pH.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: There is no mobility in an electric field -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is <strong>correct. </strong>Since the molecule has <strong>no net charge </strong>at its <strong>isoelectric point</strong>, it will <strong>not</strong> move towards <strong>either electrode </strong>in an <strong>electric field</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>pH </strong>at which the molecule carries <strong>no net charge </strong>is called an<strong> isoelectric point or isoelectric pH (pI).</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At an <strong>isoelectric point</strong>, the<strong> amino acid </strong>will<strong> carry no net charge, </strong>all the groups are <strong>ionized </strong>but the charges will cancel each other. Hence, <strong>at isoelectric point, </strong>there is<strong> no mobility in an electrical field. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Solubility and buffering capacity</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> will be </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">minimum&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">at <strong>isoelectric pH.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>buffering capacity</strong> of<strong> plasma proteins and hemoglobin </strong>is mainly due to <strong>histidine residue.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 20.</span></span></strong></p>",
      "correct_choice_id": 30421,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7684,
      "choices": [
        {
          "id": 30704,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute intermittent porphyria</span></span></span></p>"
        },
        {
          "id": 30705,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Porphyria cutanea tarda</span></span></span></p>"
        },
        {
          "id": 30706,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital erythropoietic porphyria</span></span></span></p>"
        },
        {
          "id": 30707,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hereditary coproporphyria</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old male presents to the clinic with a history of skin fragility and blistering on sun-exposed areas. He also reports significant liver disease history and excessive alcohol consumption. Laboratory tests show elevated porphyrins in urine. The patient&#39;s symptoms and laboratory findings suggest a diagnosis related to porphyrin metabolism. Which of the following types of porphyria is characterized by a deficiency in the enzyme uroporphyrinogen decarboxylase?</span></span></span></p>",
      "unique_key": "Q1829943",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924641,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Porphyria cutanea tarda</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> disease</strong> is due to <strong>deficiency of uroporphyrinogen decarboxylase.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Precipitating factors</strong> -<strong>Hepatic injury </strong>caused by environmental (<strong>ethanol</strong>) and <strong>infectious</strong> (<strong>hepatitis B virus</strong>) agents and <strong>exposure to sunlight.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Porphyrin</strong> accumulates in<strong> circulation</strong> leads to <strong>cutaneous symptoms</strong> and gets <strong>excreted in urine</strong>, turning it <strong>red to brown. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: A</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">cute intermittent porphyria: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency of <strong>Uroporphyrinogen I synthase</strong>; C/F-<strong>Abdominal pain, neuropsychiatric</strong> <strong>symptoms</strong> with <strong>increased urinary ALA and PBG.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: C</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ongenital erythropoietic porphyria: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency of <strong>Uroporphyrinogen III synthase</strong>; C/F- <strong>Photosensitivity with increased</strong> u<strong>roporphyrin I</strong> in<strong> urinary, faecal, and red cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hereditary coproporphyria:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency of <strong>Coproporphyrinogen oxidase</strong>; C/F<strong>-Photosensitivity, abdominal pain,</strong> <strong>neuropsychiatric symptoms</strong> with<strong> urinary ALA, PBG</strong>, and <strong>coproporphyrin III </strong>and <strong>faecal coproporphyrin III increased.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Porphyria cutanea tarda (PCT) </strong>is the most common form of<strong> porphyria </strong>and is characterized by a<strong> deficiency of the enzyme</strong> <strong>uroporphyrinogen decarboxylase (UROD). </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 274.</span></span></strong></p>",
      "correct_choice_id": 30705,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9038,
      "choices": [
        {
          "id": 36119,
          "text": "<p><span style=\"font-size:12.0pt;\">Increasing the synthesis and secretion of VLDL from liver resulting in high LDL levels in the blood</span></p>"
        },
        {
          "id": 36120,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibiting the binding of apoB to LDL receptor, thereby blocking the lipoprotein uptake and increasing the blood cholesterol levels</span></p>"
        },
        {
          "id": 36121,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreasing the availability of LDL receptors on the cell surface, resulting in decreased LDL uptake and high blood cholesterol level</span></p>"
        },
        {
          "id": 36122,
          "text": "<p><span style=\"font-size:12.0pt;\">Preventing the cholesterol breakdown into bile acids in the liver</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old man with coronary artery disease (CAD) is being successfully treated with anti-atherogenic medication that targets PCSK9. Following treatment, his lipid profile normalizes, and his cardiac status improves. What is the primary function of PCSK9?</span></p>",
      "unique_key": "Q8805533",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924662,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Decreasing the availability of LDL receptors on the cell surface, resulting in decreased LDL uptake and high blood cholesterol level</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) normally binds to LDL receptors and promotes their degradation in lysosomes, which prevents the receptors from being recycled back to the cell surface. This natural function of PCSK9 decreases the number of LDL receptors available on cell surfaces, especially hepatocytes, resulting in reduced LDL clearance from the bloodstream and consequently higher blood cholesterol levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anti-atherogenic medications that target PCSK9 (PCSK9 inhibitors) work by inhibiting this protein, thereby preventing LDL receptor degradation. This leads to:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Increased recycling of LDL receptors back to the cell surface</span></li><li><span style=\"font-size:12.0pt;\">Greater availability of LDL receptors on hepatocytes</span></li><li><span style=\"font-size:12.0pt;\">Enhanced clearance of LDL cholesterol from the bloodstream</span></li><li><span style=\"font-size:12.0pt;\">Reduced blood LDL cholesterol levels</span></li><li><span style=\"font-size:12.0pt;\">Improved cardiovascular outcomes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>: Increasing the synthesis and secretion of VLDL - PCSK9 does not directly affect VLDL synthesis or secretion; its primary role is related to LDL receptor regulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>: Inhibiting the binding of apoB to the LDL receptor - PCSK9 does not interfere with apoB binding to LDL receptors; it affects the degradation of LDL receptors themselves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>: Preventing the breakdown of cholesterol into bile acids - PCSK9's function is not related to cholesterol metabolism into bile acids; it specifically impacts the recycling and degradation of LDL receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understanding that PCSK9 inhibitors work by preventing PCSK9-mediated degradation of LDL receptors, thereby increasing LDL receptor availability, enhancing LDL cholesterol clearance, and lowering blood cholesterol levels in patients with coronary artery disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e:&nbsp; p 271, 275, 278-279.</span></p>",
      "correct_choice_id": 36121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7676,
      "choices": [
        {
          "id": 30672,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydroxyproline</span></span></span></p>"
        },
        {
          "id": 30673,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methionine</span></span></span></p>"
        },
        {
          "id": 30674,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cysteine</span></span></span></p>"
        },
        {
          "id": 30675,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a discussion on protein synthesis, a molecular biology instructor outlines the role of aminoacyl tRNAs in the translation process. These molecules are essential for delivering the appropriate amino acids to the ribosome for incorporation into the growing polypeptide chain. However, one of the amino acids mentioned is not directly incorporated by this process. Which amino acid does not require an aminoacyl tRNA for its incorporation into a protein?</span></span></span></p>",
      "unique_key": "Q9470094",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924687,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydroxyproline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hydroxyproline</strong> is <strong>not</strong> directly incorporated into <strong>proteins </strong>during <strong>translation by aminoacyl tRNAs</strong>. Instead, <strong>proline residues</strong> in a <strong>polypeptide chain </strong>are <strong>post-translationally</strong> modified to<strong> hydroxyproline.</strong> This modification is<strong> important </strong>in the stabilization of the <strong>collagen triple helix.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note -<strong> Derived amino acids</strong> (<strong>Ex: Hydroxyproline</strong>)<strong> do not</strong> require<strong> aminoacyl tRNA</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Methionine </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- Methionine is the <strong>first amino acid</strong> incorporated into most <strong>eukaryotic proteins</strong> and is <strong>brought</strong> to the <strong>ribosome by an aminoacyl tRNA. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Cysteine </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- Cysteine is<strong> incorporated into proteins</strong> during<strong> translation </strong>via its specific <strong>aminoacyl tRNA. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Lysine </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- Lysine is also<strong> incorporated into proteins</strong> by <strong>translation</strong> involving an <strong>aminoacyl tRNA.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture7.jpg\" style=\"height:479px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: p 25. </span></strong></span></span></p>",
      "correct_choice_id": 30672,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9033,
      "choices": [
        {
          "id": 36099,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I hyperlipoproteinemia</span></span></span></p>"
        },
        {
          "id": 36100,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type IV hyperlipoproteinemia</span></span></span></p>"
        },
        {
          "id": 36101,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type IIb hyperlipoproteinemia</span></span></span></p>"
        },
        {
          "id": 36102,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type V hyperlipoproteinemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a clinical study examining lipid metabolism disorders, researchers observe participants with markedly elevated plasma levels of chylomicrons and triacylglycerols. Which type of hyperlipoproteinemia is most consistent with these findings?</span></span></span></p>",
      "unique_key": "Q8035906",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924660,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I hyperlipoproteinemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperlipoproteinemia I/Familial lipoprotein lipase deficiency (type I)&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an<strong> autosomal recessive </strong>condition presents with <strong>fasting chylomicronemia and Hypertriacylglycerolemia</strong> due to <strong>deficiency of LPL </strong>or <strong>abnormal LPL</strong> or <strong>apo C-ll deficiency</strong> causing <strong>inactive LPL.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Slow clearance of chylomicrons</strong> and <strong>VLDL</strong> with <strong>low levels of LDL</strong> and <strong>HDL are noted.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F:<strong> Eruptive xanthoma; hepatomegaly; Pain abdomen,</strong> manifests in <strong>young age </strong>with<strong> less risk</strong> of<strong> coronary disease</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>chylomicron</strong> band in <strong>fasting plasma</strong> is the<strong> </strong>characteristic finding of the disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Familial Endogenous type </strong>- due to <strong>over production of TG </strong>by liver, <strong>elevated VLDL level </strong>&rarr; <strong>Cardiac manifestations.</strong> Associated with<strong> DM, obesity and impaired glucose tolerance.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Elevation</strong> of <strong>both CHL and TG</strong> with <strong>excessive production of apo-B </strong>&rarr; <strong>elevated LDL and VLDL. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Elevated CM and VLDL. Hypertriglyceridemia </strong>secondary to disorders like <strong>obesity, excessive alcohol intake, renal failure,</strong> <strong>pancreatitis</strong>, etc. are common. Other causes:&nbsp;<strong> hepatic lipase defect, LCAT defect and Lp(a) excess and Wolman&rsquo;s disease</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type I hyperlipoproteinemia</strong>, also known as <strong>familial lipoprotein lipase deficiency, </strong>is characterized by <strong>markedly elevated plasma</strong> <strong>levels of chylomicrons </strong>due to a <strong>deficiency of lipoprotein lipase</strong> or its <strong>cofactor apolipoprotein C-II. </strong>This leads to an <strong>inability to</strong> <strong>hydrolyze </strong>the <strong>triglycerides</strong> carried by <strong>chylomicrons</strong>, resulting in <strong>high levels of both chylomicrons and triglycerides in the plasma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p245, 246.</span></strong></span></span></p>",
      "correct_choice_id": 36099,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9014,
      "choices": [
        {
          "id": 36023,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypo alpha lipoproteinemia</span></span></span></p>"
        },
        {
          "id": 36024,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tangier Disease</span></span></span></p>"
        },
        {
          "id": 36025,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial alpha Lp-deficiency</span></span></span></p>"
        },
        {
          "id": 36026,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyper alpha lipoproteinemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man with established coronary artery disease returns with new complaints of numbness in his hands and feet. On examination, below finding is observed. His lipid panel reveals HDL cholesterol levels are markedly low. What is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/2_T4chRaU.jpg\" style=\"height:157px; width:255px\" /></span></span></span></p>",
      "unique_key": "Q1064617",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924649,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Tangier Disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Defects in ABCA1</strong>, an <strong>ATP-binding cassette (ABC) </strong>protein involved in<strong> transferring cellular cholesterol to HDL. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So<strong>, plasma HDL is low </strong>and <strong>alpha band </strong>is<strong> absent</strong> in<strong> electrophoresis. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholesterol esters </strong>are accumulated in<strong> tissues. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F: <strong>Large orange yellow tonsils</strong>,<strong> muscle atrophy</strong>,<strong> recurrent peripheral neuropathies </strong>and <strong>atherosclerosis. </strong>These are the hallmark features. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Hypo alpha lipoproteinemia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Here serum<strong> HDL is decreased </strong>&rarr;<strong> High risk for coronary artery diseases.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Familial alpha Lp-deficiency:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Have <strong>&darr;&darr;HDL and A-l, Normal- Cholesterol and TAG </strong>&rarr; <strong>Increased risk of CAD.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Hyper alpha lipoproteinemia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Increased HDL</strong> and is a<strong> rare </strong>condition apparently<strong> beneficial to health.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tangier disease</strong> by its classic presentation of<strong> orange-yellow tonsillar hypertrophy, neuropathy, and low HDL levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 7/e: P 236</span></strong></span></span></p>",
      "correct_choice_id": 36024,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7679,
      "choices": [
        {
          "id": 30684,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are right but R is not the correct explanation of A </span></span></span></p>"
        },
        {
          "id": 30685,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong </span></span></span></p>"
        },
        {
          "id": 30686,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is wrong but R is a right statement </span></span></span></p>"
        },
        {
          "id": 30687,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right and R is a correct explanation of A</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>:</strong> AIP (acute intermittent porphyria) has abdominal pain and neuropsychiatric features as common presentation.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasoning (R)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>:</strong> The above symptoms are due to accumulation of ALA and PBG. ALA inhibits ATPase in the nervous system leads to conduction paralysis. </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most appropriate interpretation of the Assertion and Reasoning provided?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "unique_key": "Q3736369",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924688,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right, and R is a correct explanation of A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>defective enzyme</strong> in <strong>acute intermittent porphyria</strong> is <strong>hydroxymethylbilane synthase (uroporphyrinogen I synthase</strong>),</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>ALA </strong>and <strong>porphobilinogen </strong>accumulate in <strong>body tissues and fluids</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F: <strong>Abdominal and neurological manifestations</strong> like <strong>sensory and motor disturbances, confusion, agitation and</strong> <strong>psychiatric problems.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No photosensitivity</span></span></strong></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture8.jpg\" style=\"height:490px; width:700px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acute Intermittent Porphyria (AIP) </strong>is marked by a <strong>lack of porphobilinogen deaminase</strong>, causing <strong>delta-aminolevulinic acid </strong>and <strong>porphobilinogen buildup</strong>, leading to<strong> abdominal pain and neuropsychiatric symptoms</strong>. This is <strong>due to ALA&#39;s neurotoxicity, </strong>which <strong>inhibits ATPase in neurons,</strong> resulting in <strong>neuronal dysfunction and paralysis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 328-329</span></strong></span></span></p>",
      "correct_choice_id": 30687,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8944,
      "choices": [
        {
          "id": 35743,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a basic structure of sphingophospholipids</span></span></span></p>"
        },
        {
          "id": 35744,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sphingosine + fatty acid forms sphingomyelin </span></span></span></p>"
        },
        {
          "id": 35745,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a basic structure of&nbsp; Glycosphingolipids</span></span></span></p>"
        },
        {
          "id": 35746,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There are 2 types of glycolipids &ndash; cerebroside &amp; ganglioside</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the picture shown to you, which of the following statements is correct?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture1_Zrl1GM1.jpg\" style=\"height:243px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q7473015",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924679,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a basic structure of Glycosphingolipids</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>structure depicted </strong>is a general representation of <strong>glycosphingolipids</strong>, which are composed of <strong>sphingosine, a fatty acid, </strong>and<strong> one</strong> or <strong>more sugar residues.</strong> They play a critical role in<strong> cell-cell communication</strong> and are<strong> found in the myelin sheath of nerve cells</strong>. <strong>Defects</strong> in the metabolism of <strong>glycosphingolipids</strong> can<strong> lead</strong> to various <strong>neurological disorders.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect </strong>because <strong>sphingophospholipids </strong>have a <strong>phosphate group</strong>, which is<strong> not </strong>shown in the<strong> picture. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option B:</strong> <strong>Incorrect </strong>because <strong>sphingomyelin</strong> is a <strong>type of sphingophospholipid</strong> and would include a <strong>phosphocholine</strong> or <strong>phosphoethanolamine </strong>group, <strong>not</strong> shown in the <strong>diagram.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option D: Correct</strong> in the <strong>classification of glycolipids</strong> but <strong>not</strong> relevant to the structure<strong> shown in the image.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycosphingolipids (Glycolipids)</strong> <strong>do not</strong> contain <strong>phosphoric acid; </strong>instead contain <strong>carbohydrates and Ceramide</strong> (<strong>sphingosine + fatty acid&nbsp;</strong> in <strong>amide linkage</strong>)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contains<strong> 2 major subtypes</strong> :<strong> Glucocerebroside &amp; Galactocerebroside </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sphingomyelins </strong>are the only<strong> sphingolipid</strong> that contain<strong> phosphate</strong> and have<strong> no sugar moiety</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 250, Vasudevan 9/ed: p 108</span></strong></span></span></p>",
      "correct_choice_id": 35745,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7656,
      "choices": [
        {
          "id": 30592,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Golgi Bodies</span></span></span></p>"
        },
        {
          "id": 30593,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitochondria</span></span></span></p>"
        },
        {
          "id": 30594,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ribosomes</span></span></span></p>"
        },
        {
          "id": 30595,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysosomes</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which organelle is primarily responsible for sorting proteins?</span></span></span></p>",
      "unique_key": "Q1131381",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924674,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Golgi bodies </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Golgi bodies</strong>, also known as the<strong> Golgi apparatus</strong>, are responsible for the <strong>sorting, packaging, </strong>and <strong>modification of proteins </strong>that have been <strong>synthesized </strong>in the <strong>endoplasmic reticulum. </strong>They play a key role in <strong>preparing proteins</strong> for their <strong>specific destinations, either</strong> <strong>within or outside the cell</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitochondria:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Electron transport chain, ATP generation, TCA cycle, beta oxidation of fatty acids, ketone body production, urea synthesis (part), heme synthesis (part), gluconeogenesis (part), pyrimidine synthesis (part).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ribosomes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Biosynthesis of proteins.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysosomes:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Degradation of proteins, carbohydrates, lipids and nucleotides</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functions of Golgi bodies: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">O-Glycosylation of proteins</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Protein sorting</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Processing of oligosaccharide chains of Glycoproteins</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 608.</span></strong></span></span></p>",
      "correct_choice_id": 30592,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9020,
      "choices": [
        {
          "id": 36047,
          "text": "<p><span style=\"font-size:12.0pt;\">CM &gt; LDL &gt; VLDL &gt; HDL</span></p>"
        },
        {
          "id": 36048,
          "text": "<p><span style=\"font-size:12.0pt;\">CM &gt; VLDL &gt; LDL &gt; HDL</span></p>"
        },
        {
          "id": 36049,
          "text": "<p><span style=\"font-size:12.0pt;\">HDL &gt; VLDL &gt; LDL &gt; CM</span></p>"
        },
        {
          "id": 36050,
          "text": "<p><span style=\"font-size:12.0pt;\">HDL &gt; VLDL &gt; LDL &gt; CM</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">In an electrophoretic separation procedure, a technician observes the migration of lipoproteins from the cathode (-) to the anode (+) sidewhich of the following correctly orders the lipoproteins from cathode to anode?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/4_03T9YxQ.jpg\" alt=\"\" width=\"400\" height=\"278\"></span></p>",
      "unique_key": "Q4920637",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924651,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;CM &gt; LDL &gt; VLDL &gt; HDL</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Plasma lipoproteins can be separated on the basis of their electrophoretic mobility:</span></p><p><span style=\"font-size:12.0pt;\">Those with higher protein content will move faster towards the anode and those with less proteins have low mobility</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Classifcation of Lipoproteins</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Depending on the density (by ultracentrifugation) or on the electrophoretic mobility, the lipoproteins in plasma are classified into five major types&nbsp;</span></p><ol><li><span style=\"font-size:12.0pt;\">Chylomicrons: Contain apoprotein B-48.</span></li><li><span style=\"font-size:12.0pt;\">Very low-density lipoproteins (VLDL) or pre-beta lipoproteins. Main apoprotein is B-100.</span></li><li><span style=\"font-size:12.0pt;\">Intermediate density lipoproteins (IDL) or broad-beta lipoproteins</span></li><li><span style=\"font-size:12.0pt;\">Low-density lipoproteins or beta lipoproteins. Major apoprotein in LDL is B-100.</span></li><li><span style=\"font-size:12.0pt;\">High-density lipoproteins or alpha lipoproteins. Major apoprotein in HDL is apo A.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Separation by Ultracentrifugation</strong></span></p><p><span style=\"font-size:12.0pt;\">The lipoproteins are characterized on the basis of their density. Fat is less dense than water; so fat floats on water. Lipoproteins with high lipid content will have a low density and so float on centrifugation. Those with high protein content will sediment easily and have a high density.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Separation by Electrophoresis</strong></span></p><p><span style=\"font-size:12.0pt;\">As a general rule, those with higher protein content will move faster towards the anode and those with fewer proteins have minimum mobility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note : pattern of electrophoresis and ultracentrifugation are different as shown in the diagram.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Electrophoresis&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Standard order from Cathode (-) to Anode (+):</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>CM &gt;LDL&gt;VLDL&gt;HDL&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ultracentrifugation: sequence is&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">CM &gt; VLDL &gt; LDL &gt; HDL</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture3_cTaOOJy.png\" width=\"2696\" height=\"2068\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Comparison of electrophoretic and ultracentrifugation patterns of lipoproteins.</span></p><p><span style=\"font-size:12.0pt;\">(VLDL: very low-density lipoproteins; IDL: intermediate density lipoproteins; LDL: low-density lipoproteins; HDL: high-density lipoproteins; FFA: free fatty acid)</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lipoprotein electrophoresis separates particles based on their <strong>protein content and charge.</strong> Understanding the typical migration pattern helps diagnose dyslipidemias and distinguish between different lipoprotein abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Lippincott 7/e: 228.</span></p>",
      "correct_choice_id": 36047,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8956,
      "choices": [
        {
          "id": 35791,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gaucher&rsquo;s disease </span></span></span></p>"
        },
        {
          "id": 35792,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Niemann Pick disease</span></span></span></p>"
        },
        {
          "id": 35793,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tay-Sachs disease</span></span></span></p>"
        },
        {
          "id": 35794,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sandhoffs disease</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A general practitioner examines a 5-year-old boy who has been brought in due to concerns about his slow development and physical health. The child has noticeable abdominal swelling and a history of unsteady gait leading to frequent falls. Recently, he experienced a convulsive episode that prompted this visit. Clinical examination reveals significant hepatosplenomegaly. Laboratory investigations, including a bone marrow biopsy, show lipid-laden foam histiocytes, and an enzyme assay indicates sphingomyelinase deficiency in the child&#39;s white blood cells?</span></span></span></p>",
      "unique_key": "Q8255380",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924642,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Niemann Pick disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to <strong>deficiency of Sphingomyelinase. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F:<strong> Mental retardation, blindness, muscular weakness, hepatosplenomegaly </strong>with <strong>Cherry red spot in macula. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Death</strong> by <strong>2 years of age.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Gaucher&rsquo;s disease type 1:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to <strong>deficiency of beta-glucocerebrosidase,</strong> C/F: <strong>Enlarged liver and spleen, erosion of long</strong> <strong>bones, mental retardation</strong> in infants but<strong> </strong><strong>no cherry red spot</strong> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Tay-Sachs disease:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to<strong> deficiency </strong>of enzyme <strong>Hexosaminidase</strong> <strong>Options A.</strong>&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F:<strong> Mental retardation, Cherry red spot</strong> in the<strong> macula and progressive deterioration.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Sandhoff&rsquo;s disease:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to <strong>deficiency of Hexosaminidase Options A</strong> and <strong>Options&nbsp; B</strong>, c/f: <strong>Neurological deficit and MR </strong>with <strong>cherry red spot.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Niemann-Pick disease</strong> is associated with <strong>sphingomyelinase deficiency</strong>, leading to the accumulation of <strong>sphingomyelin in cells</strong> and <strong>tissues</strong>. The child&#39;s symptoms, including <strong>developmental delay, hepatosplenomegaly,</strong> <strong>difficulty walking,</strong> <strong>falls, seizures,</strong> and findings of<strong> lipid-laden foam histiocytes</strong> on <strong>bone marrow</strong> <strong>biopsy,</strong> are characteristic of this disorder.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 68,251.</span></strong></span></span></p>",
      "correct_choice_id": 35792,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9027,
      "choices": [
        {
          "id": 36075,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acids</span></span></span></p>"
        },
        {
          "id": 36076,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucagon</span></span></span></p>"
        },
        {
          "id": 36077,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycerol</span></span></span></p>"
        },
        {
          "id": 36078,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Three hours after a healthy middle-aged man eats a meal that includes carbohydrates, proteins, and fats, a blood sample is drawn to assess his lipid profile. Considering normal digestive physiology and the timing of the sample in relation to his meal, which component in his blood is likely to be elevated at this point?</span></span></span></p>",
      "unique_key": "Q6091017",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924655,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After a <strong>well-balanced meal</strong> , the <strong>products of digestion</strong> such as <strong>glucose, amino acids, triacylglycerols</strong> are packaged as <strong>chylomicrons</strong> from the<strong> intestine and VLDL</strong> from the<strong> liver enter the bloodstream </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Fatty acids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Fatty acids in the <strong>blood </strong>usually <strong>increase during fasting </strong>when<strong> fat stores </strong>are mobilized for <strong>energy, </strong>not postprandially.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Glucagon</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Glucagon levels typically <strong>rise during fasting </strong>to<strong> promote glucose production</strong> and release by the <strong>liver, not</strong> after a <strong>meal </strong>when<strong> insulin is the predominant hormone.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Glycerol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Glycerol</strong> levels in the <strong>blood</strong> typically <strong>increase during triglyceride breakdown</strong>, which occurs <strong>during fasting </strong>or <strong>exercise,</strong> <strong>not postprandially.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>postprandial rise in chylomicron levels</strong> in response to a <strong>well-balanced meal</strong>, reflecting the <strong>normal physiological process </strong>of <strong>dietary fat transport.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 257-259.</span></strong></span></span></p>",
      "correct_choice_id": 36078,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8974,
      "choices": [
        {
          "id": 35863,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GM2 ganglioside</span></span></span></p>"
        },
        {
          "id": 35864,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mannose 6-phosphate</span></span></span></p>"
        },
        {
          "id": 35865,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Galactocerebroside</span></span></span></p>"
        },
        {
          "id": 35866,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Globoside</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">I-cell disease is characterized by a severe lysosomal storage disorder with symptoms manifesting early in life, including developmental delay, skeletal abnormalities, and coarse facial features. This condition results from a deficiency in a key enzyme necessary for the proper targeting of lysosomal enzymes. Without this enzyme, lysosomal proteins fail to be correctly trafficked to lysosomes. Which of the following recognition markers is not properly formed due to the deficiency of the phosphorylating enzyme in I-cell disease?<strong> </strong></span></span></span></p>",
      "unique_key": "Q8121458",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924646,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mannose 6-phosphate</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>I-cell disease </strong>is caused by a <strong>deficiency</strong> in the enzyme that adds a<strong> phosphate group to mannose residues</strong> on <strong>lysosomal enzymes,</strong> producing the<strong> mannose 6-phosphate (M6P) </strong>recognition marker<strong>. M6P </strong>is<strong> essential </strong>for <strong>directing lysosomal enzymes to lysosomes.</strong> <strong>Without</strong> this marker,<strong> enzymes </strong>are <strong>secreted outside the cell </strong>instead of being targeted to the <strong>lysosome, </strong>leading to the <strong>accumulation</strong> of<strong> undigested substrates</strong> in<strong> lysosomes </strong>and the characteristic features of<strong> I-cell disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: GM2 ganglioside</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a<strong> component of neuronal cell membranes</strong> and is accumulated in <strong>Tay-Sachs disease</strong>, <strong>not I-cell</strong> <strong>disease,</strong> due to a <strong>deficiency in Hexosaminidase A, </strong>an enzyme <strong>unrelated to the defect in I-cell disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Galactocerebroside</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a <strong>major</strong> component of <strong>myelin sheath in the nervous system</strong>. <strong>Accumulation</strong> of <strong>galactocerebroside</strong> due to a <strong>deficiency of galactocerebrosidase </strong>enzyme is seen in<strong> Krabbe disease</strong>, not I-cell disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Globoside</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Accumulation of globosides </strong>occurs in <strong>Fabry disease </strong>due to a<strong> deficiency in alpha-galactosidase A, </strong>which is <strong>not</strong> related to the enzyme deficiency observed in <strong>I-cell disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inclusion cell (I-cell) disease </strong>is a condition in which<strong> lysosomes lack in enzymes</strong> but are <strong>seen in blood.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mannose-6-phosphate</strong> is the<strong> marker enzyme </strong>to target the <strong>nascent enzymes to lysosomes. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In<strong> I CELL DISEASE,</strong> the carbohydrate units are <strong>not</strong> added to the enzyme &rarr; <strong>Mannose-6-phosphate deficient </strong>enzymes <strong>cannot </strong>reach their destination (<strong>protein targeting defect</strong>). </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p586</span></strong></span></span></p>",
      "correct_choice_id": 35864,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7666,
      "choices": [
        {
          "id": 30632,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True</span></span></span></p>"
        },
        {
          "id": 30633,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">False</span></span></span></p>"
        },
        {
          "id": 30634,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insufficient Information </span></span></span></p>"
        },
        {
          "id": 30635,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Is the statement &quot;Calreticulin is considered a chaperone protein&quot; correct?</span></span></span></p>",
      "unique_key": "Q6074619",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924680,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Calreticulin </strong>is a<strong> chaperone protein. </strong>It is<strong> located</strong> in the <strong>endoplasmic reticulum (ER) </strong>of cells and has several functions, including ensuring<strong> proper folding of newly synthesized proteins </strong>and <strong>maintaining calcium homeostasis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Molecular Chaperones are </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HSP 70</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HSP 90</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HSP 40 [<strong>Cochaperone</strong>]</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>BiP</strong> [<strong>Immunoglobulin</strong> heavy chain <strong>binding protein</strong>]</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose Regulated Protein</strong> [GRP-94]</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calreticulin</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calnexin.</span></span></span></strong></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 608-610.</span></span></strong></p>",
      "correct_choice_id": 30632,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9026,
      "choices": [
        {
          "id": 36071,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial type III hyperlipoproteinemia</span></span></span></p>"
        },
        {
          "id": 36072,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abetalipoproteinemia</span></span></span></p>"
        },
        {
          "id": 36073,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL receptor mutation</span></span></span></p>"
        },
        {
          "id": 36074,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial LPL deficiency (type l)</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old male with a familial history of increased cholesterol levels presents with an isolated elevation in LDL. His father and brother had similar lipid abnormalities. Given the isolated increase in LDL and family history, what is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q3494015",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924654,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL receptor mutation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipoproteinemia</strong> are categorized by <strong>Frederickson&#39;s Classification </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial hypercholesterolemia (FH) results in</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> severe <strong>hypercholesterolemia </strong>associated with<strong> premature atherosclerosis. </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>defect is in the gene</strong> for the<strong> LDL receptor or mutation </strong>in the ligand region of<strong> apo B100</strong> &rarr; so, <strong>LDL</strong> is <strong>not</strong> cleared from the<strong> </strong><strong>blood.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Familial type llI hyperlipoproteinemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> due to the <strong>abnormality</strong> in <strong>apoE</strong> , remnant <strong>clearance</strong> by the<strong> liver is defective</strong> resulting <strong>in increased levels of chylomicron and VLDL remnants.&nbsp;</strong>It can cause <strong>hypercholesterolemia, atherosclerosis, and xanthomas.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Abetalipoproteinemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Defective</strong> loading of <strong>apo B</strong> with lipid &rarr; <strong>absence of formation of chylomicrons, VLDL or LDL</strong>,<strong> low</strong> <strong>blood acylglycerols</strong> with accumulation of it in the<strong> intestine and liver.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Familial LPL deficiency (type l):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Due to deficiency </strong>of <strong>LPL or abnormal LPL or apo C-ll deficiency</strong> &rarr;&nbsp; <strong>Hypertriacylglycerolemia</strong> with slow clearance of chylomicrons and VLDL, <strong>low levels of LDL and HDL. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>LDL receptor </strong>gene mutation is characterized by <strong>isolated elevated LDL cholesterol levels </strong>and a <strong>family history of hypercholesterolemia</strong> and early <strong>cardiovascular disease.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 275,276.</span></strong></span></span></p>",
      "correct_choice_id": 36073,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9008,
      "choices": [
        {
          "id": 35999,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Chylomicronemia</span></span></span></p>"
        },
        {
          "id": 36000,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Hypercholesterolemia</span></span></span></p>"
        },
        {
          "id": 36001,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abetalipoproteinemia</span></span></span></p>"
        },
        {
          "id": 36002,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Broad Beta Disease</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the clinical presentation (as shown in image), which of the following is the most probable diagnosis? </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/1_BiC30gi.jpg\" style=\"height:190px; width:284px\" /></span></span></span></p>",
      "unique_key": "Q1136238",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924648,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Hypercholesterolemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>deposition of lipids</strong> in<strong> subcutaneous tissue</strong> leads to <strong>xanthomas.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xanthelasma </strong>are<strong> lipid deposits under the periorbital skin </strong>and contain mainly <strong>cholesterol.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tendinous xanthoma </strong>are found <strong>over the tendons.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deposits of lipids </strong>in <strong>cornea</strong> lead to<strong> corneal arcus</strong>; indicating <strong>hypercholesterolemia</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Familial Chylomicronemia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F- <strong>Hepatomegaly, eruptive xanthoma and abdominal pain.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Abetalipoproteinemia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low levels of serum triglycerides,</strong> <strong>cholesterol and phospholipids</strong>. C/F-<strong> Blindness </strong>due to <strong>degenerative changes</strong> in <strong>retina</strong> and <strong>spiny projections </strong>in<strong> erythrocytes (acanthocytes).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Broad Beta Disease:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Palmar xanthoma</strong> and <strong>increased risk for vascular disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Familial Hypercholesterolemia</strong> is characterized by <strong>high LDL cholesterol levels </strong>and the presence of <strong>xanthomas</strong>, which are deposits of <strong>cholesterol in the skin and tendons</strong>, due to a<strong> genetic defect in LDL receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: P245, 246.</span></strong></span></span></p>",
      "correct_choice_id": 36000,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7651,
      "choices": [
        {
          "id": 30572,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methionine</span></span></span></p>"
        },
        {
          "id": 30573,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aspartic acid</span></span></span></p>"
        },
        {
          "id": 30574,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valine</span></span></span></p>"
        },
        {
          "id": 30575,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Arginine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following can be homologous substitution for isoleucine in a protein?</span></span></span></p>",
      "unique_key": "Q9072098",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924671,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Valine</strong> is a <strong>homologous substitution</strong> for i<strong>soleucine</strong> because they are <strong>both branched-chain, nonpolar, hydrophobic amino acids </strong>of <strong>similar size</strong>. This substitution is likely to have the <strong>least </strong>impact on the<strong> protein&#39;s structure</strong> and<strong> function compared</strong> to the <strong>other</strong> <strong>options.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Methionine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - Although methionine is also <strong>nonpolar</strong> and <strong>relatively hydrophobic,</strong> it has a<strong> different side chain</strong> that includes a <strong>sulfur atom</strong>, which <strong>can </strong>affect the<strong> protein</strong> <strong>differently</strong> than<strong> valine or isoleucine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Aspartic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - This <strong>amino acid </strong>is<strong> polar</strong> and <strong>carries a negative charge </strong>at physiological <strong>pH</strong>, making it a<strong> non-homologous</strong> <strong>substitution</strong> for the<strong> nonpolar isoleucine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Arginine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - Arginine is a <strong>positively charged amino</strong> <strong>acid</strong> at <strong>physiological pH</strong> and is much <strong>larger, </strong>making it a <strong>non-homologous</strong> <strong>substitution for isoleucine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><u><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></u></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conservative (Homologous) Substitution:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>One amino acid</strong> replaced by<strong> another amino acid</strong> of<strong> similar characteristics</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Examples of<strong> homologous substitutio</strong>n is shown in the diagram <strong>given below.B</strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture13.jpg\" style=\"height:352px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nonconservative (Nonhomologous) Substitution:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>One amino acid </strong>replaced by <strong>another amino acid</strong> of <strong>different characteristics</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 390.</span></strong></span></span></p>",
      "correct_choice_id": 30574,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7655,
      "choices": [
        {
          "id": 30588,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High performance liquid chromatography</span></span></span></p>"
        },
        {
          "id": 30589,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mass spectrometry</span></span></span></p>"
        },
        {
          "id": 30590,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-ray crystallography</span></span></span></p>"
        },
        {
          "id": 30591,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NMR spectrometry</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A researcher is utilizing different analytical techniques to study protein structures. Each method has a specific utility in the determination of primary, secondary, tertiary, or quaternary structures of proteins. Among the listed techniques, which one does NOT directly determine the structure of proteins?</span></span></span></p>",
      "unique_key": "Q6649481",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924673,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High performance liquid chromatography</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>High performance liquid chromatography</strong>&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(HPLC) is a technique primarily <strong>used </strong>for <strong>separating and identifying components</strong> in a <strong>mixture</strong>, analyzing compound <strong>purity, or identifying concentration</strong>. It <strong>does not </strong>directly provide information on the <strong>structure of</strong> <strong>proteins</strong> at the level of detail that the other mentioned techniques do.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note - The <strong>proteins are extracted and purified</strong> by <strong>various chromatography techniques</strong> such as<strong> ion exchange, adsorption, partition,</strong> s<strong>ize exclusion, affinity</strong>, <strong>HPLC</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Mass spectrometry</strong> can determine the<strong> primary structure </strong>(sequence of <strong>amino acids)</strong> of<strong> proteins </strong>and <strong>post-translational</strong> <strong>modifications. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>X-ray crystallography</strong> is <strong>used to </strong>determine the<strong> three-dimensional structure of a protein </strong>at <strong>atomic resolution. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;NMR spectrometry </strong>can provide detailed <strong>information </strong>about the<strong> structure and dynamics of proteins</strong>, particularly in <strong>solution.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methods for Separating and Purifying Biomolecules </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Salt fractionation </strong>(e.g.,<strong> precipitation of proteins </strong>with <strong>ammonium sulfate</strong>)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chromatography: Paper, ion exchange, affinity, thin-layer, gas-liquid, high-pressure liquid, gel filtration </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Electrophoresis</strong>: <strong>Paper, high-voltage, agarose, cellulose acetate, starch gel, polyacrylamide gel, SDS-polyacrylamide gel</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultracentrifugation</span></span></span></strong></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methods for Determining Biomolecular Structures </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elemental analysis </span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">UV, visible, infrared, and NMR spectroscopy </span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Use of <strong>acid or alkaline</strong> <strong>hydrolysis</strong> to<strong> degrade</strong> the biomolecule understudy into its<strong> basic constituents </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Use of a battery </strong>of <strong>enzymes</strong> of known <strong>specificity</strong> to<strong> degrade the biomolecule</strong> under study (e.g., <strong>proteases, nucleases,</strong> <strong>glycosidases</strong>)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mass spectrometry </span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Specific sequencing methods</strong> (e.g., for<strong> proteins and nucleic acids</strong>) </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-ray crystallography </span></span></span></strong></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 29/e: p 2, Vasudevan 9/e: p 45.</span></span></strong></p>",
      "correct_choice_id": 30588,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7681,
      "choices": [
        {
          "id": 30692,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uroporphyrinogen Synthase</span></span></p>"
        },
        {
          "id": 30693,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uroporphyrinogen III Synthase</span></span></p>"
        },
        {
          "id": 30694,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uroporphyrinogen Decarboxylase</span></span></p>"
        },
        {
          "id": 30695,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coproporphyrinogen Oxidase</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old boy presents to the pediatric clinic with a notably disfigured face, pronounced photosensitivity, stained teeth, and laboratory tests revealing elevated levels of Coproporphyrin-I. Based on these clinical findings, which enzyme deficiency is most likely responsible for this patient&#39;s condition?</span></span></span></p>",
      "unique_key": "Q3101063",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924639,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uroporphyrinogen III Synthase</span></strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Congenital erythropoietic porphyria </strong>has <strong>AR inheritance </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The defective enzyme - <strong>uroporphyrinogen III synthase </strong>leads to <strong>increase</strong> in levels of <strong>porphyrin I</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Their <strong>excretion in urine</strong> makes the <strong>urine dark red </strong>in colour (port wine appearance)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reactive oxygen species</strong> are the cause for attacks of <strong>dermatitis </strong>and scarring which leads to <strong>severe disfigurement</strong> referred to as <strong>&lsquo;monkey face</strong>&rsquo;. Also<strong> photosensitivity</strong> is reported.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When<strong> UV light </strong>is reflected <strong>onto teeth a red fluorescence </strong>is seen; this is called <strong>erythrodontia. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Uroporphyrinogen Synthase</strong> - A <strong>deficiency</strong> in this enzyme would <strong>not</strong> lead to the specific accumulation of <strong>Coproporphyrin-I</strong>, nor would it directly result in the<strong> clinical syndrome</strong> described.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Uroporphyrinogen Decarboxylase</strong> - <strong>Deficiency</strong> in this enzyme leads to <strong>Porphyria Cutanea Tarda (PCT)</strong>, the <strong>most common</strong> type of <strong>porphyria,</strong> which presents with<strong> skin fragility and blistering on sun-exposed areas, </strong>but <strong>not</strong> the <strong>severe disfigurement </strong>or <strong>erythrodontia </strong>seen in this case.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Coproporphyrinogen Oxidase</strong> - <strong>Deficiency </strong>of this enzyme results in <strong>Hereditary Coproporphyria, </strong>which can cause <strong>photosensitivity and neurological symptoms </strong>but<strong> does not </strong>typically present with the <strong>severe facial disfigurement </strong>or <strong>stained teeth </strong>as described in the patient&#39;s presentation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Congenital Erythropoietic Porphyria (CEP),</strong> a <strong>rare disorder </strong>caused by a <strong>deficiency in Uroporphyrinogen III Synthase.</strong> The accumulation of <strong>specific porphyrins </strong>leads to symptoms including <strong>photosensitivity, facial disfigurement, and stained teeth,</strong> <strong>emphasizing </strong>the critical role of the<strong> heme biosynthesis pathway</strong> in maintaining <strong>normal physiological functions</strong> and the <strong>diverse</strong> <strong>clinical manifestations</strong> that can<strong> arise</strong> from <strong>its disruption.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 327-329</span></span></strong></p>",
      "correct_choice_id": 30693,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7630,
      "choices": [
        {
          "id": 30488,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosine</span></span></span></p>"
        },
        {
          "id": 30489,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysine</span></span></span></p>"
        },
        {
          "id": 30490,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leucine</span></span></span></p>"
        },
        {
          "id": 30491,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspartate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which amino acid can be converted into an intermediate that plays a role in both the citric acid cycle and the urea cycle?</span></span></span></p>",
      "unique_key": "Q3477995",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924663,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspartate</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspartate </strong>is a <strong>glucogenic amino acid</strong>, which carries <strong>NH<sub>4</sub> <sup>+ </sup>into the urea cycle.</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspartate aminotransferase </strong>catalyzes the<strong> direct </strong>transamination of <strong>aspartate to oxaloacetate</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxaloacetate </strong>may <strong>either be utilized </strong>in the <strong>citric acid cycle or undergo gluconeogenesis</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Argininosuccinate synthetase </strong>catalyzes the<strong> condensation </strong>of <strong>citrulline </strong>and<strong> aspartate </strong>to form <strong>argininosuccinate</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this manner, <strong>one of the two nitrogens of urea </strong>is introduced into the <strong>urea cycle.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u>Other Options:</u></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Tyrosine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - Tyrosine is primarily used for <strong>protein synthesis </strong>and the production of <strong>hormones and neurotransmitters.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Lysine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - Lysine is an <strong>essential amino acid </strong>involved in <strong>protein synthesis </strong>but is <strong>not </strong>a <strong>direct precursor to citric acid </strong>or<strong> urea cycle intermediates</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Leucine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - Leucine is a <strong>branched-chain amino acid </strong>used in <strong>protein synthesis </strong>and can be <strong>oxidized for energy </strong>but does <strong>not directly feed </strong>into the <strong>citric acid cycle or urea cycle</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspartate </strong>can be <strong>converted to oxaloacetate</strong>, which is an <strong>intermediate </strong>in the <strong>citric acid cycle</strong>. Furthermore, aspartate is involved in the <strong>urea cycle</strong>, where it <strong>donates an amino group </strong>for the <strong>synthesis of arginine</strong>, which is then <strong>cleaved </strong>to form <strong>urea and ornithine. </strong>This connection highlights <strong>aspartate&#39;s </strong>role in <strong>both energy production </strong>and <strong>nitrogen disposal</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e p 203, 247.</span></strong></span></span></p>",
      "correct_choice_id": 30491,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9022,
      "choices": [
        {
          "id": 36055,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></span></span></p>"
        },
        {
          "id": 36056,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL</span></span></span></p>"
        },
        {
          "id": 36057,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL</span></span></span></p>"
        },
        {
          "id": 36058,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 36-year-old man who consumes a fat-free, high-carbohydrate diet finds that he continues to gain weight. Considering the dietary influence on lipoprotein metabolism, which apoprotein is most likely to be elevated in his blood?</span></span></span></p>",
      "unique_key": "Q3754305",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924653,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Excess Carbohydrates </strong>in the <strong>body</strong> are converted to<strong> Acetyl CoA. </strong>These are then <strong>converted to Fatty acid</strong>, which <strong>gets</strong> <strong>esterified</strong> to form<strong> Endogenous TGs. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>VLDL </strong>is the<strong> carrier of endogenous TGs</strong>. So,<strong> blood VLDL</strong> level is <strong>raised.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Chylomicrons:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carry <strong>TAG </strong>from<strong> gut</strong> to <strong>muscle and adipose tissue</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: HDL:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carry<strong> cholesterol</strong> from <strong>peripheral tissues to liver</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: LDL:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carry<strong> cholesterol </strong>from <strong>liver to peripheral tissues</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>fat-free, high-carbohydrate diet</strong> can lead to <strong>increased synthesis of VLDL</strong> (Very Low-Density Lipoprotein) in the<strong> liver.</strong> <strong>VLDL</strong> is responsible for <strong>transporting endogenously synthesized triglycerides</strong>, which the<strong> body produces</strong> from <strong>excess carbohydrates,</strong> to <strong>adipose tissue</strong> for <strong>storage</strong>. This could contribute to <strong>ongoing obesity </strong>despite the <strong>absence of dietary fat.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 255-257.</span></strong></span></span></p>",
      "correct_choice_id": 36058,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9048,
      "choices": [
        {
          "id": 36159,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></span></span></p>"
        },
        {
          "id": 36160,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></span></span></p>"
        },
        {
          "id": 36161,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL</span></span></span></p>"
        },
        {
          "id": 36162,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with coronary artery disease (CAD), currently undergoing treatment, is advised to implement lifestyle modifications and monitor his lipid profile quarterly. Among the lipoproteins evaluated, which one is characterized by the lowest lipid-to-protein ratio?</span></span></span></p>",
      "unique_key": "Q2490427",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924667,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> HDL</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>High-density lipoprotein (HDL) </strong>is known for having the <strong>highest protein </strong>content relative to its <strong>lipid content </strong>among the <strong>various lipoproteins, </strong>resulting in the <strong>lowest lipid-to-protein ratio</strong>. This <strong>high protein </strong>content contributes to <strong>HDL&#39;s </strong>denser nature compared to other lipoproteins and its role in <strong>reverse cholesterol transport</strong>, where it <strong>facilitates </strong>the removal of <strong>excess cholesterol from cells </strong>and <strong>atheromatous plaques </strong>in the <strong>arteries</strong>, transporting it back to the <strong>liver for excretion or recycling</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Chylomicrons</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are the <strong>largest lipoproteins </strong>with the <strong>highest lipid content, </strong>primarily <strong>triglycerides</strong>, thus having a <strong>high lipid-to-protein ratio.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: VLDL (Very Low-Density Lipoprotein)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: VLDL particles are <strong>rich in triglycerides </strong>and have a <strong>higher lipid-to-protein ratio </strong>compared to <strong>HDL </strong>but<strong> lower than chylomicrons.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: LDL (Low-Density Lipoprotein)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: LDL carries mostly<strong> cholesterol </strong>and has a <strong>lower lipid-to-protein ratio </strong>than <strong>VLDL </strong>and <strong>chylomicrons but higher than HDL</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/screenshot-2024-04-18-182641.png\" style=\"height:410px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among<strong> different HDL particles</strong>, <strong>percentage of lipids </strong>seen will be:&nbsp;&nbsp; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL<sub>1</sub>&nbsp;: 65%</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL2&nbsp; : 67%</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL3&nbsp; : 43%</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pre&beta;-HDL : 30</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 478-479, 484.</span></strong></span></span></p>",
      "correct_choice_id": 36161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9036,
      "choices": [
        {
          "id": 36111,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">245 mg/dl</span></span></span></p>"
        },
        {
          "id": 36112,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">135 mg/dl</span></span></span></p>"
        },
        {
          "id": 36113,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">85 mg/dl</span></span></span></p>"
        },
        {
          "id": 36114,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">45 mg/dl</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman undergoes routine health screening, including a lipid profile, while fasting. Her results show a total cholesterol of 300 mg/dL, HDL cholesterol of 25 mg/dL, and triglycerides of 150 mg/dL. Utilizing the Friedewald equation to assess her cardiovascular risk, what is the LDL cholesterol level in this patient?</span></span></span></p>",
      "unique_key": "Q2855174",
      "question_audio": null,
      "question_video": null,
      "map_id": 32924661,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">245 mg/dl</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>total blood cholesterol</strong> in the <strong>fasting state </strong>is <strong>equal</strong> to the <strong>sum </strong>of the <strong>cholesterol in LDL + cholesterol in HDL +</strong> <strong>cholesterol in VLDLs. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This<strong> last term </strong>is calculated by <strong>dividing the triacylglycerol value by 5 </strong>because<strong> cholesterol </strong>accounts for about <strong>1/5 </strong>of the <strong>volume of VLDL in fasted blood</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">300 = LDL cholesterol + 25+150/5</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL cholesterol = 300-55= 245 mg/dl.</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> Friedewald equation</strong>, used to estimate the <strong>level of LDL cholesterol</strong>, is<strong> LDL = Total Cholesterol - HDL - (Triglycerides / 5).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan, 9/e: p241, 242, Lippincott 7/e: p 244</span></strong></span></span></p>",
      "correct_choice_id": 36111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}